QUARTERLY REPORT

Q1 2022 — Quarterly report on Form 10-Q

Q1 2022PDF · 74 pages577 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2022
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 	58-0628465
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta Georgia 	30313
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.25 Par Value 	KO 	New York Stock Exchange
0.500% Notes Due 2024 	KO24 	New York Stock Exchange
1.875% Notes Due 2026 	KO26 	New York Stock Exchange
0.750% Notes Due 2026 	KO26C 	New York Stock Exchange
1.125% Notes Due 2027 	KO27 	New York Stock Exchange
0.125% Notes Due 2029 	KO29A 	New York Stock Exchange
0.125% Notes Due 2029 	KO29B 	New York Stock Exchange
0.400% Notes Due 2030 	KO30B 	New York Stock Exchange
1.250% Notes Due 2031 	KO31 	New York Stock Exchange
0.375% Notes Due 2033 	KO33 	New York Stock Exchange
0.500% Notes Due 2033 	KO33A 	New York Stock Exchange
1.625% Notes Due 2035 	KO35 	New York Stock Exchange
1.100% Notes Due 2036 	KO36 	New York Stock Exchange
0.950% Notes Due 2036 	KO36A 	New York Stock Exchange
0.800% Notes Due 2040 	KO40B 	New York Stock Exchange
1.000% Notes Due 2041 	KO41 	New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐

-- 1 of 74 --

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock 	Shares Outstanding as of April 26, 2022
$0.25 Par Value 	4,335,028,727

-- 2 of 74 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 	1
Part I. Financial Information
Item 1. 	Financial Statements 	2
Consolidated Statements of Income Three Months Ended April 1, 2022 and April 2, 2021 	2
Consolidated Statements of Comprehensive Income Three Months Ended April 1, 2022 and April 2, 2021 	3
Consolidated Balance Sheets April 1, 2022 and December 31, 2021 	4
Consolidated Statements of Cash Flows Three Months Ended April 1, 2022 and April 2, 2021 	5
Notes to Consolidated Financial Statements 	6
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	26
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	38
Item 4. 	Controls and Procedures 	38
Part II. Other Information
Item 1. 	Legal Proceedings 	38
Item 1A. 	Risk Factors 	40
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	41
Item 6. 	Exhibits 	41
Signatures 	45

-- 3 of 74 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,”
“will” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the
future — including statements relating to volume growth, share of sales and earnings per share growth, and statements expressing general views about future operating
results — are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken
not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-
looking statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present
expectations or projections. These risks and uncertainties include, but are not limited to, the possibility that the assumptions used to calculate our estimated aggregate
incremental tax and interest liability related to the potential unfavorable outcome of the ongoing tax dispute with the U.S. Internal Revenue Service could significantly change;
those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2021; and those
described from time to time in our future reports filed with the Securities and Exchange Commission.
1

-- 4 of 74 --

Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended
April 1,
2022 April 2,
2021
Net Operating Revenues 	$ 	10,491 $ 	9,020
Cost of goods sold 	4,091 	3,505
Gross Profit 	6,400 	5,515
Selling, general and administrative expenses 	2,967 	2,669
Other operating charges 	28 	124
Operating Income 	3,405 	2,722
Interest income 	78 	66
Interest expense 	182 	442
Equity income (loss) — net 	262 	279
Other income (loss) — net 	(105) 	138
Income Before Income Taxes 	3,458 	2,763
Income taxes 	665 	508
Consolidated Net Income 	2,793 	2,255
Less: Net income (loss) attributable to noncontrolling interests 	12 	10
Net Income Attributable to Shareowners of The Coca-Cola Company 	$ 	2,781 $ 	2,245
Basic Net Income Per Share 	$ 	0.64 $ 	0.52
Diluted Net Income Per Share $ 	0.64 $ 	0.52
Average Shares Outstanding — Basic 	4,332 	4,307
Effect of dilutive securities 	25 	23
Average Shares Outstanding — Diluted 	4,357 	4,330
Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
1
1
1
2

-- 5 of 74 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended
April 1,
2022
April 2,
2021
Consolidated Net Income 	$ 	2,793 $ 	2,255
Other Comprehensive Income:
Net foreign currency translation adjustments 	1,009 	4
Net gains (losses) on derivatives 	64 	104
Net change in unrealized gains (losses) on available-for-sale debt securities 	(35) 	(60)
Net change in pension and other postretirement benefit liabilities 	85 	420
Total Comprehensive Income 	3,916 	2,723
Less: Comprehensive income (loss) attributable to noncontrolling interests 	145 	10
Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company 	$ 	3,771 $ 	2,713
Refer to Notes to Consolidated Financial Statements.
3

-- 6 of 74 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
April 1,
2022 December 31,
2021
ASSETS
Current Assets
Cash and cash equivalents 	$ 	7,681 $ 	9,684
Short-term investments 	736 	1,242
Total Cash, Cash Equivalents and Short-Term Investments 	8,417 	10,926
Marketable securities 	1,939 	1,699
Trade accounts receivable, less allowances of $512 and $516, respectively 	4,641 	3,512
Inventories 	3,741 	3,414
Prepaid expenses and other current assets 	3,418 	2,994
Total Current Assets 	22,156 	22,545
Equity method investments 	18,198 	17,598
Other investments 	788 	818
Other noncurrent assets 	6,392 	6,731
Deferred income tax assets 	2,006 	2,129
Property, plant and equipment, less accumulated depreciation of $9,104 and $8,942, respectively 	9,784 	9,920
Trademarks with indefinite lives 	14,388 	14,465
Goodwill 	19,598 	19,363
Other intangible assets 	754 	785
Total Assets 	$ 	94,064 $ 	94,354
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses 	$ 	13,272 $ 	14,619
Loans and notes payable 	3,610 	3,307
Current maturities of long-term debt 	1,039 	1,338
Accrued income taxes 	866 	686
Total Current Liabilities 	18,787 	19,950
Long-term debt 	37,052 	38,116
Other noncurrent liabilities 	8,252 	8,607
Deferred income tax liabilities 	3,132 	2,821
The Coca-Cola Company Shareowners’ Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 	1,760 	1,760
Capital surplus 	18,388 	18,116
Reinvested earnings 	69,969 	69,094
Accumulated other comprehensive income (loss) 	(13,340) 	(14,330)
Treasury stock, at cost — 2,709 and 2,715 shares, respectively 	(51,932) 	(51,641)
Equity Attributable to Shareowners of The Coca-Cola Company 	24,845 	22,999
Equity attributable to noncontrolling interests 	1,996 	1,861
Total Equity 	26,841 	24,860
Total Liabilities and Equity 	$ 	94,064 $ 	94,354
Refer to Notes to Consolidated Financial Statements.
4

-- 7 of 74 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
Three Months Ended
April 1,
2022 April 2,
2021
Operating Activities
Consolidated net income 	$ 	2,793 $ 	2,255
Depreciation and amortization 	324 	366
Stock-based compensation expense 	87 	58
Deferred income taxes 	41 	377
Equity (income) loss — net of dividends 	(247) 	(250)
Foreign currency adjustments 	100 	(20)
Significant (gains) losses — net 	25 	1
Other operating charges 	38 	69
Other items 	(70) 	157
Net change in operating assets and liabilities 	(2,468) 	(1,377)
Net Cash Provided by Operating Activities 	623 	1,636
Investing Activities
Purchases of investments 	(835) 	(1,466)
Proceeds from disposals of investments 	1,323 	1,375
Acquisitions of businesses, equity method investments and nonmarketable securities 	(5) 	(4)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 	218 	2
Purchases of property, plant and equipment 	(217) 	(216)
Proceeds from disposals of property, plant and equipment 	16 	11
Other investing activities 	(354) 	17
Net Cash Provided by (Used in) Investing Activities 	146 	(281)
Financing Activities
Issuances of debt 	1,052 	5,588
Payments of debt 	(1,045) 	(3,044)
Issuances of stock 	449 	183
Purchases of stock for treasury 	(546) 	(104)
Dividends 	(1,906) 	(1,810)
Other financing activities 	(979) 	(449)
Net Cash Provided by (Used in) Financing Activities 	(2,975) 	364
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 	173 	(18)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period 	(2,033) 	1,701
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 	10,025 	7,110
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 	7,992 	8,811
Less: Restricted cash and restricted cash equivalents at end of period 	311 	327
Cash and Cash Equivalents at End of Period 	$ 	7,681 $ 	8,484
Refer to Notes to Consolidated Financial Statements.
5

-- 8 of 74 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by
U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated
Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2021.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included.
Operating results for the three months ended April 1, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. Sales of our
ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the
beverage business may be affected by weather conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter
of 2022 and the first quarter of 2021 ended on April 1, 2022 and April 2, 2021, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of the day of
the week on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as
of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to each of those quarters. We use the proportion of
each quarter’s actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being
recognized at a standard rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year marketing expenditures
that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any change in the full year estimate is recognized in the quarter in which the
change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash
equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line
item other noncurrent assets on our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification
of counterparties and procedures to monitor our concentrations of credit risk.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated
statements of cash flows (in millions):
April 1,
2022 December 31,
2021
Cash and cash equivalents 	$ 	7,681 $ 	9,684
Restricted cash and restricted cash equivalents included in other noncurrent assets 	311 	341
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	7,992 $ 	10,025
Amounts represent restricted cash and restricted cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of our European and Canadian
pension plans. Refer to Note 4.
Restricted cash and restricted cash equivalents include amounts related to assets held for sale. Refer to Note 2.
1,2
1
2
6

-- 9 of 74 --

April 2,
2021
December 31,
2020
Cash and cash equivalents 	$ 	8,484 $ 	6,795
Restricted cash and restricted cash equivalents included in other noncurrent assets 	327 	315
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	8,811 $ 	7,110
Amounts represent restricted cash and restricted cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of our European and Canadian
pension plans. Refer to Note 4.
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $5 million and $4 million during the three months ended April 1,
2022 and April 2, 2021, respectively.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the three months ended April 1, 2022 and April 2, 2021 totaled $218
million and $2 million, respectively. In 2022, we sold our ownership interest in one of our equity method investments for cash proceeds of $123 million. We recognized a net
gain of $13 million as a result of the sale, which was recorded in the line item other income (loss) — net in our consolidated statement of income.
Assets and Liabilities Held for Sale
The Company had certain bottling operations in Asia Pacific that met the criteria to be classified as held for sale. As a result, we were required to record their assets and
liabilities at the lower of carrying value or fair value less any costs to sell. As the fair value less any costs to sell exceeded the carrying value, the related assets and liabilities
were recorded at their carrying value. These assets and liabilities were included in the Bottling Investments operating segment. The Company expects these bottling operations
to be refranchised during the second half of 2022.
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale and were included in the line items prepaid
expenses and other current assets and accounts payable and accrued expenses, respectively, in our consolidated balance sheets (in millions):
April 1,
2022 	December 31, 2021
Cash, cash equivalents and short-term investments 	$ 	220 $ 	228
Trade accounts receivable, less allowances 	15 	21
Inventories 	50 	55
Prepaid expenses and other current assets 	42 	36
Other noncurrent assets 	36 	9
Deferred income tax assets 	6 	6
Property, plant and equipment — net 	287 	282
Goodwill 	36 	37
Assets held for sale 	$ 	692 $ 	674
Accounts payable and accrued expenses 	$ 	137 $ 	139
Accrued income taxes 	5 	4
Other noncurrent liabilities 	9 	9
Deferred income tax liabilities 	5 	5
Liabilities held for sale 	$ 	156 $ 	157
1
1
7

-- 10 of 74 --

NOTE 3: NET OPERATING REVENUES
The following table presents net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States 	International 	Total
Three Months Ended April 1, 2022
Concentrate operations 	$ 	1,641 $ 	4,083 $ 	5,724
Finished product operations 	1,882 	2,885 	4,767
Total 	$ 	3,523 $ 	6,968 $ 	10,491
Three Months Ended April 2, 2021
Concentrate operations 	$ 	1,410 $ 	3,572 $ 	4,982
Finished product operations 	1,483 	2,555 	4,038
Total 	$ 	2,893 $ 	6,127 $ 	9,020
Refer to Note 16 for disclosures of net operating revenues by operating segment and Corporate.
NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions):
Fair Value with
Changes Recognized in
Income
Measurement Alternative
— No Readily
Determinable Fair Value
April 1, 2022
Marketable securities 	$ 	357 $ 	—
Other investments 	745 	43
Other noncurrent assets 	1,493 	—
Total equity securities 	$ 	2,595 $ 	43
December 31, 2021
Marketable securities 	$ 	376 $ 	—
Other investments 	771 	47
Other noncurrent assets 	1,576 	—
Total equity securities 	$ 	2,723 $ 	47
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended
April 1,
2022
April 2,
2021
Net gains (losses) recognized during the period related to equity securities 	$ 	(100) $ 	155
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	(132) 	14
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period 	$ 	32 $ 	141
8

-- 11 of 74 --

Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized 	Estimated
Fair Value	Cost 	Gains 	Losses
April 1, 2022
Trading securities $ 	41 $ 	— $ 	(1) $ 	40
Available-for-sale securities 1,933 	25 	(165) 	1,793
Total debt securities $ 	1,974 $ 	25 $ 	(166) $ 	1,833
December 31, 2021
Trading securities $ 	39 $ 	1 $ 	— $ 	40
Available-for-sale securities 1,648 	33 	(132) 	1,549
Total debt securities $ 	1,687 $ 	34 $ 	(132) $ 	1,589
The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions):
April 1, 2022 	December 31, 2021
Trading Securities Available-for-Sale
Securities 	Trading Securities Available-for-Sale
Securities
Marketable securities $ 	40 $ 	1,542 	$ 	40 $ 	1,283
Other noncurrent assets — 	251 	— 	266
Total debt securities 	$ 	40 $ 	1,793 	$ 	40 $ 	1,549
The contractual maturities of these available-for-sale debt securities as of April 1, 2022 were as follows (in millions):
Cost Estimated
Fair Value
Within 1 year 	$ 	70 $ 	68
After 1 year through 5 years 	1,649 	1,504
After 5 years through 10 years 	43 	57
After 10 years 	171 	164
Total 	$ 	1,933 $ 	1,793
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended
April 1,
2022 April 2,
2021
Gross gains 	$ 	1 $ 	1
Gross losses 	(5) 	(4)
Proceeds 	231 	158
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain minimum solvency capital requirements. The
Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The
Company uses one of our consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of our European and
Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of $1,580 million and $1,670 million as of April 1, 2022 and
December 31, 2021, respectively, which are classified in the line item other noncurrent assets in our consolidated balance sheets because the assets are not available to satisfy
our current obligations.
9

-- 12 of 74 --

NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
April 1,
2022 December 31,
2021
Raw materials and packaging 	$ 	2,274 $ 	2,133
Finished goods 	1,165 	982
Other 	302 	299
Total inventories 	$ 	3,741 $ 	3,414
NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value
Derivatives Designated as Hedging Instruments 	Balance Sheet Location April 1,
2022 December 31,
2021
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	189 $ 	151
Foreign currency contracts 	Other noncurrent assets 	66 	27
Interest rate contracts 	Prepaid expenses and other current assets 	— 	1
Interest rate contracts 	Other noncurrent assets 	— 	282
Total assets 	$ 	255 $ 	461
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	40 $ 	15
Foreign currency contracts 	Other noncurrent liabilities 	38 	17
Interest rate contracts 	Other noncurrent liabilities 	442 	14
Total liabilities 	$ 	520 $ 	46
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
Refer to Note 15 for additional information related to the estimated fair value.
1,2
1
1
2
10

-- 13 of 74 --

The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging instruments (in millions):
Fair Value
Derivatives Not Designated as Hedging Instruments 	Balance Sheet Location April 1,
2022 	December 31, 2021
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	90 $ 	53
Foreign currency contracts 	Other noncurrent assets 	11 	—
Commodity contracts 	Prepaid expenses and other current assets 	270 	131
Commodity contracts 	Other noncurrent assets 	18 	3
Other derivative instruments 	Prepaid expenses and other current assets 	20 	9
Total assets 	$ 	409 $ 	196
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	68 $ 	34
Foreign currency contracts 	Other noncurrent liabilities 	1 	9
Commodity contracts 	Accounts payable and accrued expenses 	— 	6
Commodity contracts 	Other noncurrent liabilities 	3 	1
Total liabilities 	$ 	72 $ 	50
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
Refer to Note 15 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty
exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring
collateral for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial
instrument increases. In addition, the Company’s master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same
counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the
risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency
exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other
comprehensive income (loss) (“AOCI”) and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period
the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. The
maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows from sales outside the United States and U.S.
dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase
foreign currency options and collars (principally euro, British pound sterling and Japanese yen) to hedge certain portions of forecasted cash flows denominated in foreign
currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in
the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset
by losses in the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company’s foreign currency cash flow
hedging program were $7,569 million and $7,399 million as of April 1, 2022 and December 31, 2021, respectively.
The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to
changes in foreign currency exchange rates. For this hedging program, the Company recognizes in earnings each period the changes in carrying values of these foreign currency
denominated assets and
1,2
1
1
2
11

-- 14 of 74 --

liabilities due to changes in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded in AOCI with an immediate reclassification into
earnings for the changes in fair values attributable to fluctuations in foreign currency exchange rates. The total notional values of derivatives that were designated as cash flow
hedges for the Company’s foreign currency denominated assets and liabilities were $1,524 million and $1,994 million as of April 1, 2022 and December 31, 2021.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted
purchases of materials used in our manufacturing process. These derivative instruments were designated as part of the Company’s commodity cash flow hedging program. The
objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional value of derivatives that
were designated and qualified for this program was $10 million as of December 31, 2021. As of April 1, 2022, we did not have any commodity futures contracts nor other
derivative instruments on various commodities designated as a cash flow hedge.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk to interest rate fluctuations through the use of derivative financial
instruments. From time to time, the Company enters into interest rate swap agreements and designates these instruments as part of the Company’s interest rate cash flow hedging
program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s future interest payments. As of April 1,
2022 and December 31, 2021, we did not have any interest rate swaps designated as a cash flow hedge.
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income (“OCI”), AOCI
and earnings (in millions):
Gain (Loss)
Recognized
in OCI Location of Gain (Loss) Recognized in Income Gain (Loss) Reclassified
from AOCI into Income
Three Months Ended April 1, 2022
Foreign currency contracts 	$ 	81 Net operating revenues 	$ 	8
Foreign currency contracts 	6 Cost of goods sold 	1
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(5) Other income (loss) — net 	(11)
Total 	$ 	82 	$ 	(3)
Three Months Ended April 2, 2021
Foreign currency contracts 	$ 	(23) Net operating revenues 	$ 	(23)
Foreign currency contracts 	(5) Cost of goods sold 	(1)
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	87 Other income (loss) — net 	66
Interest rate contracts 	121 Interest expense 	(5)
Total 	$ 	180 	$ 	36
As of April 1, 2022, the Company estimates that it will reclassify into earnings during the next 12 months net gains of $93 million from the pretax amount recorded in AOCI as
the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from fluctuations
in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt relating to
fluctuations in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the offsetting
changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. When a derivative is no longer
designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that
time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or has been
extinguished. The total notional values of derivatives that were designated and qualified as fair value hedges of this type were $11,717 million and $12,113 million as of April 1,
2022 and December 31, 2021, respectively.
12

-- 15 of 74 --

The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings (in millions):
Hedging Instruments and Hedged Items 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
April 1,
2022 April 2,
2021
Interest rate contracts 	Interest expense 	$ 	(711) $ 	(395)
Fixed-rate debt 	Interest expense 	709 	396
Net impact to interest expense 	$ 	(2) $ 	1
Net impact of fair value hedging instruments 	$ 	(2) $ 	1
The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments
Carrying Values of
Hedged Items Included in the Carrying Values of Hedged
Items Remaining for Which Hedge Accounting
Has Been Discontinued
Balance Sheet Location of Hedged Items April 1,
2022 December 31,
2021 April 1,
2022 December 31,
2021 April 1,
2022 December 31,
2021
Current maturities of long-term debt 	$ 	—$ 	200 $ 	— $ 	1 $ 	— $ 	—
Long-term debt 	11,443 	12,353 	(445) 	255 	220 	228
Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments in
a number of foreign operations. For derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the fair
values of the derivative financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net
investments being hedged. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the
carrying values of the designated portions of the non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency
translation adjustments. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Values 	Gain (Loss) Recognized in OCI
as of 	Three Months Ended
April 1,
2022 December 31,
2021 April 1,
2022 April 2,
2021
Foreign currency contracts 	$ 	54 $ 	40 $ 	(6) $ 	(8)
Foreign currency denominated debt 	12,457 	12,812 	355 	483
Total 	$ 	12,511 $ 	12,852 $ 	349 $ 	475
The Company did not reclassify any gains or losses related to net investment hedges from AOCI into earnings during the three months ended April 1, 2022 and April 2, 2021. In
addition, the Company did not have any ineffectiveness related to net investment hedges during the three months ended April 1, 2022 and April 2, 2021. The cash inflows and
outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in the line item other investing activities in our consolidated
statement of cash flows.
1
1
13

-- 16 of 74 --

Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency,
interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The
changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and
liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately
recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize
the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes
in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues,
cost of goods sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency
economic hedges were $5,623 million and $4,258 million as of April 1, 2022 and December 31, 2021, respectively.
The Company uses interest rate contracts as economic hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark
interest rates. The total notional value of derivatives related to our economic hedges of this type was $200 million as of December 31, 2021. As of April 1, 2022, we did not
have any interest rate contracts used as economic hedges.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and vehicle
fuel. The changes in the fair values of these economic hedges are immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or selling,
general and administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related to our economic hedges of this type
were $859 million and $908 million as of April 1, 2022 and December 31, 2021, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings (in millions):
Derivatives Not Designated as Hedging Instruments 	Location of Gain (Loss) Recognized in Income
Gain (Loss)
Recognized in Income
Three Months Ended
April 1,
2022 April 2,
2021
Foreign currency contracts 	Net operating revenues 	$ 	(15) $ 	(1)
Foreign currency contracts 	Cost of goods sold 	13 	(8)
Foreign currency contracts 	Other income (loss) — net 	42 	(28)
Interest rate contracts 	Interest expense 	— 	(187)
Commodity contracts 	Cost of goods sold 	160 	82
Other derivative instruments 	Selling, general and administrative expenses 	(3) 	8
Other derivative instruments 	Other income (loss) — net 	— 	(3)
Total 	$ 	197 $ 	(137)
NOTE 7: DEBT AND BORROWING ARRANGEMENTS
During the three months ended April 1, 2022, the Company retired upon maturity fixed interest rate U.S. dollar-denominated debentures of $288 million with an interest rate of
8.500 percent.
NOTE 8: COMMITMENTS AND CONTINGENCIES
Guarantees
As of April 1, 2022, we were contingently liable for guarantees of indebtedness owed by third parties of $567 million, of which $87 million was related to variable interest
entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have
various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make
under the guarantees. However, management has concluded that the likelihood of any significant amounts being paid by our Company under these guarantees is not probable.
14

-- 17 of 74 --

We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is
probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is
reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of
currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. We establish reserves to remove some or all of the tax benefit of any
of our tax positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not “more likely than not” to be
sustained; (2) the tax position is “more likely than not” to be sustained but for a lesser amount; or (3) the tax position is “more likely than not” to be sustained but not in the
financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be
examined by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities, such as
legislation and statutes, legislative intent, regulations, rulings and caselaw and their applicability to the facts and circumstances of the tax position; and (3) each tax position is
evaluated without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position
is audited and finally resolved. The number of years subject to tax audits or tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously
reserved because of a failure to meet the “more likely than not” recognition threshold would be recognized in income tax expense in the quarter in which the uncertainty
disappears under any one of the following conditions: (1) the tax position is “more likely than not” to be sustained; (2) the tax position, amount, and/or timing is ultimately
settled through negotiation or litigation; or (3) the statute of limitations for the tax position has expired. Refer to Note 14.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the U.S. Internal Revenue Service (“IRS”) seeking approximately $3.3 billion
of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from
certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in a closing agreement resolving that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances or relevant
federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation
methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
15

-- 18 of 74 --

The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the
Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by approximately
$138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid
by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would
become payable to the Company in accordance with the Opinion. The Tax Court reserved ruling on the effect of Brazilian legal restrictions on the payment of royalties by the
Company’s licensee in Brazil until after the Tax Court issues its opinion in the separate case of 3M Co. & Subs. v. Commissioner, T.C. Docket No. 5816-13 (filed March 11,
2013). Once the Tax Court issues its opinion in 3M Co. & Subs. v. Commissioner, the Company expects the Tax Court thereafter to render another opinion, and ultimately a
final decision, in the Company’s case.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on appeal
and vigorously defend its position.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors and we reviewed and considered relevant laws, rules, and regulations,
including, but not limited to, the Opinion and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-founded legal
claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not the Company’s
tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the methodology asserted by
the IRS and affirmed in the Opinion (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on the required probability
analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we
recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment
applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in
accordance with the Opinion and the Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of April 1, 2022. However, we
updated our calculation of the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of the application of
the required probability analysis to these updated calculations and the accrual of interest through the current reporting period, we updated our tax reserve as of April 1, 2022 to
$410 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinion affirming such positions, it is possible that some portion or all of the adjustment
proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would likely be subject to significant additional liabilities for tax
years 2007 through 2009, and potentially also for subsequent years, which could have a material adverse impact on the Company’s financial position, results of operations and
cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinion, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to subsequent years, with consent of the
federal courts. This impact would include taxes and interest accrued through December 31, 2021 for the 2007 through 2009 litigated tax years and for subsequent tax years from
2010 through 2021. The calculations incorporated the estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and
Jobs Act. The Company estimates that the potential aggregate incremental tax and interest liability could be approximately $13 billion as of December 31, 2021. Additional
income tax and interest would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the
continued application of the Tax Court Methodology for the three months ended April 1, 2022 would increase the potential aggregate incremental tax and interest liability by
approximately $250 million. Additionally, we currently project the continued application of the Tax Court Methodology in future years, assuming similar
16

-- 19 of 74 --

facts and circumstances as of December 31, 2021, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by approximately3.5
percent.
The Company does not know when the Tax Court will issue its opinion regarding the effect of Brazilian legal restrictions on the payment of royalties by the Company’s licensee
in Brazil for the 2007 through 2009 tax years. After the Tax Court issues its opinion on the Company’s Brazilian licensee, the Company and the IRS will be provided time to
agree on the tax impact, if any, of both opinions, after which the Tax Court would render a final decision in the case. The Company will have 90 days thereafter to file a notice
of appeal to the U.S. Court of Appeals for the Eleventh Circuit and pay the tax liability and interest related to the 2007 through 2009 tax years. The Company currently estimates
that the payment to be made at that time related to the 2007 through 2009 tax years, which is included in the above estimate of the potential aggregate incremental tax and
interest liability, would be approximately $5.0 billion (including interest accrued through April 1, 2022), plus any additional interest accrued through the time of payment. Some
or all of this amount would be refunded if the Company were to prevail on appeal.
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many
different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the
Company’s self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claims
history. Our self-insurance reserves totaled $228 million and $229 million as of April 1, 2022 and December 31, 2021, respectively.
NOTE 9: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of The Coca-Cola Company’s
shareowners’ equity, which also includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in,
our consolidated balance sheet as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
April 1,
2022 December 31,
2021
Net foreign currency translation adjustments 	$ 	(11,719) $ 	(12,595)
Accumulated net gains (losses) on derivatives 	84 	20
Unrealized net gains (losses) on available-for-sale debt securities 	(97) 	(62)
Adjustments to pension and other postretirement benefit liabilities 	(1,608) 	(1,693)
Accumulated other comprehensive income (loss) 	$ 	(13,340) $ 	(14,330)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Three Months Ended April 1, 2022
Shareowners of
The Coca-Cola Company Noncontrolling
Interests 	Total
Consolidated net income 	$ 	2,781 $ 	12 $ 	2,793
Other comprehensive income:
Net foreign currency translation adjustments 	876 	133 	1,009
Net gains (losses) on derivatives 	64 	— 	64
Net change in unrealized gains (losses) on available-for-sale debt securities 	(35) 	— 	(35)
Net change in pension and other postretirement benefit liabilities 	85 	— 	85
Total comprehensive income (loss) 	$ 	3,771 $ 	145 $ 	3,916
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
2
17

-- 20 of 74 --

The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees’ OCI (in millions):
Three Months Ended April 1, 2022 Before-Tax
Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	1,324 $ 	(240) $ 	1,084
Reclassification adjustments recognized in net income 	200 	— 	200
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(670) 	— 	(670)
Gains (losses) on net investment hedges arising during the period 	349 	(87) 	262
Net foreign currency translation adjustments 	$ 	1,203 $ 	(327) $ 	876
Derivatives:
Gains (losses) arising during the period 	$ 	83 $ 	(21) $ 	62
Reclassification adjustments recognized in net income 	3 	(1) 	2
Net gains (losses) on derivatives 	$ 	86 $ 	(22) $ 	64
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(46) $ 	8 $ 	(38)
Reclassification adjustments recognized in net income 	4 	(1) 	3
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	(42) $ 	7 $ 	(35)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	68 $ 	(4) $ 	64
Reclassification adjustments recognized in net income 	28 	(7) 	21
Net change in pension and other postretirement benefit liabilities 	$ 	96 $ 	(11) $ 	85
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	1,343 $ 	(353) $ 	990
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Three Months Ended April 2, 2021 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	624 $ 	(23)$ 	601
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(954) 	— 	(954)
Gains (losses) on net investment hedges arising during the period 	475 	(118) 	357
Net foreign currency translation adjustments 	$ 	145 $ 	(141)$ 	4
Derivatives:
Gains (losses) arising during the period 	$ 	174 $ 	(43)$ 	131
Reclassification adjustments recognized in net income 	(36) 	9 	(27)
Net gains (losses) on derivatives 	$ 	138 $ 	(34)$ 	104
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(92)$ 	30 $ 	(62)
Reclassification adjustments recognized in net income 	3 	(1) 	2
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	(89)$ 	29 $ 	(60)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	453 $ 	(109)$ 	344
Reclassification adjustments recognized in net income 	101 	(25) 	76
Net change in pension and other postretirement benefit liabilities 	$ 	554 $ 	(134)$ 	420
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	748 $ 	(280)$ 	468
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
1
2
1
2
1
1
2
1
2
18

-- 21 of 74 --

The following table presents the amounts and line items in our consolidated statement of income where adjustments reclassified from AOCI into income were recorded
(in millions):
Amount Reclassified from
AOCI into Income
Description of AOCI Component 	Financial Statement Line Item Three Months Ended April 1,
2022
Foreign currency translation adjustments:
Divestitures, deconsolidations and other 	Other income (loss) — net 	$ 	200
Income before income taxes 	200
Income taxes 	—
Consolidated net income 	$ 	200
Derivatives:
Foreign currency contracts 	Net operating revenues 	$ 	(8)
Foreign currency contracts 	Cost of goods sold 	(1)
Foreign currency contracts 	Interest expense 	1
Foreign currency contracts 	Other income (loss) — net 	11
Income before income taxes 	3
Income taxes 	(1)
Consolidated net income 	$ 	2
Available-for-sale debt securities:
Sale of debt securities 	Other income (loss) — net 	$ 	4
Income before income taxes 	4
Income taxes 	(1)
Consolidated net income 	$ 	3
Pension and other postretirement benefit liabilities:
Recognized net actuarial loss 	Other income (loss) — net 	$ 	29
Recognized prior service cost (credit) 	Other income (loss) — net 	(1)
Income before income taxes 	28
Income taxes 	(7)
Consolidated net income 	$ 	21
Related to the sale of our ownership interest in one of our equity method investments and the issuance of additional shares of stock by one of our equity method investees. Refer to Note 2 and
Note 15, respectively.
1
1
19

-- 22 of 74 --

NOTE 10: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and
equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended April 1, 2022
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss)Common StockCapital Surplus Treasury Stock
Non-controlling
Interests
December 31, 2021 	4,325 $ 	24,860$ 	69,094 $ 	(14,330)$ 	1,760 $ 	18,116$ 	(51,641)$ 	1,861
Comprehensive income (loss) 	— 	3,916 	2,781 	990 	— 	— 	— 	145
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.44 per share) 	— 	(1,906) 	(1,906) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(9) 	— 	— 	— 	— 	— 	(9)
Acquisition of interests held by
noncontrolling owners 	— 	(1) 	— 	— 	— 	— 	— 	(1)
Purchases of treasury stock 	(8) 	(471) 	— 	— 	— 	— 	(471) 	—
Impact related to stock-based
compensation plans 	14 	451 	— 	— 	— 	271 	180 	—
Other activities 	— 	1 	— 	— 	— 	1 	— 	—
April 1, 2022 	4,331 $ 	26,841$ 	69,969 $ 	(13,340)$ 	1,760 $ 	18,388$ 	(51,932)$ 	1,996
Shareowners of The Coca-Cola Company
Three Months Ended April 2, 2021 Common Shares
Outstanding 	Total Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common
Stock Capital
Surplus Treasury Stock
Non-
controlling
Interests
December 31, 2020 	4,302 $ 	21,284 $ 	66,555 $ 	(14,601) $ 	1,760 $ 	17,601 $ 	(52,016) $ 	1,985
Adoption of accounting standards 	— 	19 	19 	— 	— 	— 	— 	—
Comprehensive income (loss) 	— 	2,723 	2,245 	468 	— 	— 	— 	10
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.42 per share) 	— 	(1,810) 	(1,810) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(18) 	— 	— 	— 	— 	— 	(18)
Impact related to stock-based
compensation plans 	9 	134 	— 	— 	— 	29 	105 	—
April 2, 2021 	4,311 $ 	22,332 $ 	67,009 $ 	(14,133) $ 	1,760 $ 	17,630 $ 	(51,911) $ 	1,977
Represents the adoption of Accounting Standards Update 2019-12, Simplifying the Accounting for Income Taxes, effective January 1, 2021.
NOTE 11: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended April 1, 2022, the Company recorded other operating charges of $28 million. These charges primarily consisted of $22 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, $10 million related to the
Company’s productivity and reinvestment program and $2 million related to the restructuring of our manufacturing operations in the United States. These charges were partially
offset by a net gain of $5 million, which included the reimbursement of distributor termination fees for BA Sports Nutrition, LLC (“BodyArmor”) recorded in the prior year
partially offset by various transition and transaction costs, employee retention costs and the amortization of noncompete agreements, and income of $1 million related to the
Company’s strategic realignment initiatives primarily as a result of a revision to estimated severance costs accrued in the prior year.
During the three months ended April 2, 2021, the Company recorded other operating charges of $124 million. These charges primarily consisted of $93 million related to the
Company’s strategic realignment initiatives and $18 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included $4
million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $9 million related to tax litigation
expense.
1
1
20

-- 23 of 74 --

Refer to Note 8 for additional information related to the tax litigation. Refer to Note 12 for additional information on the Company’s productivity and reinvestment program.
Refer to Note 15 for additional information on the fairlife acquisition. Refer to Note 16 for the impact these charges had on our operating segments and Corporate.
Other Nonoperating Items
Interest Expense
During the three months ended April 2, 2021, the Company recorded charges of $58 million related to the extinguishment of long-term debt.
Equity Income (Loss) — Net
During the three months ended April 1, 2022 and April 2, 2021, the Company recorded net gains of $5 million and $37 million, respectively. These amounts represent the
Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Other Income (Loss) — Net
During the three months ended April 1, 2022, the Company recorded a net loss of $104 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities and a net loss of $24 million as a result of one of our equity method investees
issuing additional shares of its stock.
During the three months ended April 2, 2021, the Company recognized a net gain of $133 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded pension settlement charges of $54 million related to
our strategic realignment initiatives.
Refer to Note 4 for additional information on equity and debt securities. Refer to Note 15 for additional information on one of our equity method investees issuing additional
shares of its stock. Refer to Note 16 for the impact these items had on our operating segments and Corporate.
NOTE 12: RESTRUCTURING
In February 2012, the Company announced a productivity and reinvestment program designed to strengthen our brands and reinvest our resources to drive long-term profitable
growth. The program was expanded multiple times, with the last expansion occurring in April 2017. While we expect most of the remaining initiatives included in this program,
which are primarily designed to further simplify and standardize our organization, to be completed by the end of 2023, certain initiatives may extend into 2024.
During the three months ended April 1, 2022 and April 2, 2021, the Company incurred expenses of $10 million and $18 million, respectively, related to our productivity and
reinvestment program. These expenses primarily included internal and external costs associated with the implementation of these initiatives and were recorded in the line item
other operating charges in our consolidated statements of income. Refer to Note 16 for the impact these expenses had on our operating segments and Corporate. The Company
has incurred total pretax expenses of $4,054 million related to this program since it commenced.
21

-- 24 of 74 --

NOTE 13: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Plans
Other Postretirement
Benefit Plans
Three Months Ended
April 1,
2022
April 2,
2021
April 1,
2022
April 2,
2021
Service cost 	$ 	22 $ 	24 $ 	2 $ 	2
Interest cost 	51 	44 	4 	4
Expected return on plan assets 	(149) 	(151) 	(4) 	(4)
Amortization of prior service credit 	— 	— 	(1) 	(1)
Amortization of net actuarial loss 	29 	47 	— 	1
Net periodic benefit cost (income) 	(47) 	(36) 	1 	2
Settlement charges 	— 	54 	— 	—
Total cost (income) 	$ 	(47)$ 	18 $ 	1 $ 	2
The weighted-average expected long-term rates of return on plan assets used in computing 2022 net periodic benefit cost (income) were 7.00 percent for pension plans and 4.00 percent for
other postretirement benefit plans.
Settlement charges were primarily related to our strategic realignment initiatives.
All of the amounts in the table above, other than service cost, were recorded in the line item other income (loss) — net in our consolidated statements of income. During the
three months ended April 1, 2022, the Company contributed $3 million to our pension trusts, and we anticipate making additional contributions of approximately $24 million
during the remainder of 2022. The Company contributed $5 million to our pension trusts during the three months ended April 2, 2021.
NOTE 14: INCOME TAXES
The Company recorded income taxes of $665 million (19.2 percent effective tax rate) and $508 million (18.4 percent effective tax rate) during the three months ended April 1,
2022 and April 2, 2021, respectively.
The Company’s effective tax rates for the three months ended April 1, 2022 and April 2, 2021 vary from the statutory U.S. federal income tax rate of21.0 percent primarily due
to the tax impact of significant operating and nonoperating items, as described in Note 11, along with the tax benefits of having significant earnings generated outside the United
States and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the statutory U.S. rate.
On November 18, 2020, the Tax Court issued the Opinion regarding the Company’s 2015 litigation with the IRS involving transfer pricing tax adjustments in which the court
predominantly sided with the IRS. The Company strongly disagrees with the Opinion and intends to vigorously defend its position. Refer to Note 8.
NOTE 15: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
April 1, 2022 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,258 $ 	220 $ 	16 	$ 	101 $ 	— 	$ 	2,595
Debt securities 	— 	1,822 	11 	— 	— 	1,833
Derivatives 	154 	510 	— 	— 	(432) 	232
Total assets 	$ 	2,412 $ 	2,552 $ 	27 	$ 	101 $ 	(432) 	$ 	4,660
Liabilities:
Contingent consideration liability 	$ 	— $ 	— $ 	612 	$ 	— $ 	— 	$ 	612
Derivatives 	— 	592 	— 	— 	(580) 	12
Total liabilities 	$ 	— $ 	592 $ 	612 	$ 	— $ 	(580) 	$ 	624
1
2
1
2
3 	4
1
1
2 	6 	8
5
2 	7 	8
22

-- 25 of 74 --

Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are
included to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
Represents the fair value of future milestone payments related to our acquisition of fairlife in 2020, which are contingent on fairlife achieving certain financial targets through 2024 and, if
achieved, are payable in 2023 and 2025. These milestone payments are based on agreed-upon formulas related to fairlife’s operating results, the resulting values of which are not subject to a
ceiling.
The Company is obligated to return $ 70 million in cash collateral it has netted against its derivative positions.
The Company has the right to reclaim $ 344 million in cash collateral it has netted against its derivative positions.
The Company’s derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $ 137 million in the line item prepaid expenses and other current assets,
$95 million in the line item other noncurrent assets and $12 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our
derivatives portfolio.
December 31, 2021 	Level 1 	Level 2 	Level 3 	Other Netting
Adjustment Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,372$ 	230 $ 	17 $ 	104 $ 	— $ 	2,723
Debt securities 	— 	1,556 	33 	— 	— 	1,589
Derivatives 	69 	588 	— 	— 	(459) 	198
Total assets 	$ 	2,441$ 	2,374$ 	50 $ 	104 $ 	(459) $ 	4,510
Liabilities:
Contingent consideration liability 	$ 	—$ 	—$ 	590 $ 	— $ 	— $ 	590
Derivatives 	— 	96 	— 	— 	(82) 	14
Total liabilities 	$ 	—$ 	96$ 	590 $ 	— $ 	(82) $ 	604
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are
included to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
Represents the fair value of future milestone payments related to our acquisition of fairlife in 2020, which are contingent on fairlife achieving certain financial targets through 2024 and, if
achieved, are payable in 2023 and 2025. These milestone payments are based on agreed-upon formulas related to fairlife’s operating results, the resulting values of which are not subject to a
ceiling.
The Company is obligated to return $ 331 million in cash collateral it has netted against its derivative positions.
The Company does not have the right to reclaim any cash collateral it has netted against its derivative positions.
The Company’s derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $ 198 million in the line item other noncurrent assets and $14 million in
the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the three months ended April 1, 2022 and April 2, 2021.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not
significant for the three months ended April 1, 2022 and April 2, 2021.
1
2
3
4
5
6
7
8
3 	4
1
1
2 	6 	8
5
2 	7 	8
1
2
3
4
5
6
7
8
23

-- 26 of 74 --

Nonrecurring Fair Value Measurements
We recognized a net loss of $24 million on assets measured at fair value on a nonrecurring basis during the three months ended April 1, 2022. We did not recognize any gains or
losses on assets measured at fair value on a nonrecurring basis during the three months ended April 2, 2021. The net loss in 2022 was recorded as a result of an equity method
investee issuing additional shares of its stock. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its
investment. This net loss was determined using Level 2 inputs and primarily resulted from the recognition of cumulative translation losses.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents; short-term investments; trade accounts receivable; accounts payable and accrued expenses; and loans and notes payable
approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs
based on quoted prices for those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-based expectations for
interest rates, credit risk and the contractual terms of the debt instruments. As of April 1, 2022, the carrying value and fair value of our long-term debt, including the current
portion, were $38,091 million and $36,522 million, respectively. As of December 31, 2021, the carrying value and fair value of our long-term debt, including the current
portion, were $39,454 million and $40,311 million, respectively.
NOTE 16: OPERATING SEGMENTS
Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
Europe, Middle
East & Africa Latin
America North
America Asia Pacific Global Ventures Bottling
Investments 	Corporate 	Eliminations 	Consolidated
As of and for the Three Months Ended April 1, 2022
Net operating revenues:
Third party 	$ 	1,661 $ 	1,214 $ 	3,589$ 	1,231 $ 	729 $ 	2,042 	$ 	25$ 	— $ 	10,491
Intersegment 	172 	— 	1 	180 	— 	2 	— 	(355) 	—
Total net operating revenues 	1,833 	1,214 	3,590 	1,411 	729 	2,044 	25 	(355) 	10,491
Operating income (loss) 	1,007 	760 	1,056 	664 	51 	193 	(326) 	— 	3,405
Income (loss) before income taxes 	1,023 	757 	1,064 	670 	56 	393 	(505) 	— 	3,458
Identifiable operating assets 	8,092 	1,988 	26,395 	2,574 	7,755 	10,710 	17,564 	— 	75,078
Investments 	415 	633 	19 	232 	— 	13,193 	4,494 	— 	18,986
As of and for the Three Months Ended April 2, 2021
Net operating revenues:
Third party 	$ 	1,462 $ 	909 $ 	2,936$ 	1,232 $ 	570 $ 	1,894 	$ 	17$ 	— $ 	9,020
Intersegment 	161 	— 	1 	170 	— 	2 	— 	(334) 	—
Total net operating revenues 	1,623 	909 	2,937 	1,402 	570 	1,896 	17 	(334) 	9,020
Operating income (loss) 	820 	552 	792 	686 	26 	141 	(295) 	— 	2,722
Income (loss) before income taxes 	830 	555 	816 	695 	27 	317 	(477) 	— 	2,763
Identifiable operating assets 	8,335 	1,650 	19,792 	2,332 	7,843 	10,426 	19,843 	— 	70,221
Investments 	466 	595 	343 	249 	4 	13,833 	4,282 	— 	19,772
As of December 31, 2021
Identifiable operating assets 	$ 	7,908 $ 	1,720 $ 	25,730$ 	2,355 $ 	7,949 $ 	10,312 	$ 	19,964$ 	— $ 	75,938
Investments 	436 	594 	21 	230 	— 	12,669 	4,466 	— 	18,416
Principally equity method investments and other investments in bottling companies.
Property, plant and equipment — net in South Africa represented 17 percent, 15 percent and 16 percent of consolidated property, plant and equipment — net as of April 1, 2022, April 2, 2021
and December 31, 2021, respectively.
Property, plant and equipment — net in the Philippines represented 10 percent of consolidated property, plant and equipment — net as of April 1, 2022, April 2, 2021 and December 31, 2021.
2 	3 	2,3
1
2 	3 	2,3
1
2 	3 	2,3
1
1
2
3
24

-- 27 of 74 --

During the three months ended April 1, 2022, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were increased by $19 million for North America and were reduced by $14 million for Corporate related to
our acquisition of BodyArmor in 2021. Refer to Note 11.
• Operating income (loss) and income (loss) before income taxes were reduced by $22 million for Corporate related to the remeasurement of our contingent consideration
liability to fair value in conjunction with the fairlife acquisition in 2020. Refer to Note 15.
• Operating income (loss) and income (loss) before income taxes were reduced by $11 million and $12 million, respectively, for North America related to the restructuring of
our manufacturing operations in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $10 million for Corporate due to the Company’s productivity and reinvestment program.
Refer to Note 12.
• Income (loss) before income taxes was increased by $5 million for Bottling Investments due to the Company’s proportionate share of significant operating and nonoperating
items recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $104 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt
securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
• Income (loss) before income taxes was reduced by $24 million for Corporate due to one of our equity method investees issuing additional shares of its stock. Refer to
Note 15.
During the three months ended April 2, 2021, the results of our operating segments and Corporate were impacted by the following items:
• Operating income (loss) and income (loss) before income taxes were reduced by $50 million for Europe, Middle East and Africa, $11 million for Latin America, $12
million for North America and $13 million for Asia Pacific, and operating income (loss) and income (loss) before income taxes were reduced by $7 million and $61 million,
respectively, for Corporate due to the Company’s strategic realignment initiatives.
• Operating income (loss) and income (loss) before income taxes were reduced by $19 million for North America related to the restructuring of our manufacturing operations
in the United States.
• Operating income (loss) and income (loss) before income taxes were reduced by $18 million for Corporate due to the Company’s productivity and reinvestment program.
Refer to Note 12.
• Operating income (loss) and income (loss) before income taxes were reduced by $9 million for Corporate related to tax litigation expense. Refer to Note 8.
• Operating income (loss) and income (loss) before income taxes were reduced by $4 million for Corporate related to the remeasurement of our contingent consideration
liability to fair value in conjunction with the fairlife acquisition. Refer to Note 15.
• Income (loss) before income taxes was increased by $133 million for Corporate related to realized and unrealized gains and losses on equity securities and trading debt
securities as well as realized gains and losses on available-for-sale debt securities. Refer to Note 4.
• Income (loss) before income taxes was increased by $5 million for Bottling Investments and $32 million for Corporate due to the Company’s proportionate share of
significant operating and nonoperating items recorded by certain of our equity method investees.
• Income (loss) before income taxes was reduced by $58 million for Corporate related to charges associated with the extinguishment of long-term debt.
25

-- 28 of 74 --

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements.
On March 8, 2022, the Company announced the suspension of its business in Russia as a result of the conflict between Russia and Ukraine. In addition, the conflict has caused a
disruption of our business in Ukraine. Given the rapidly changing conditions, the Company will continue to monitor and assess the situation as circumstances evolve. As a point
of reference, in 2021, the Company’s business in Russia and Ukraine contributed approximately 2 percent of the Company’s unit case volume and approximately 1 percent and
2 percent of the Company’s consolidated net operating revenues and operating income, respectively. As of April 1, 2022, the carrying value of the Company’s assets related to
Russia and Ukraine is less than
0.5 percent of the Company’s total assets. In addition, as of April 1, 2022, the Company had an approximate 21 percent ownership interest in Coca-Cola HBC AG (“CCH”), the
Company’s bottling and distribution partner in the region. If CCH were to record an impairment charge, we would be required to record our proportionate share of the charge as
a reduction of equity income (loss) — net in our consolidated statement of income.
During the three months ended April 1, 2022, the effects of the COVID-19 pandemic, including the resurgence of the virus in certain countries and the related actions by
governments to attempt to contain the spread of the virus, continued to negatively impact our business. While uncertainties caused by the COVID-19 pandemic remain, and
factors such as the state of the supply chain, labor shortages and the inflationary environment are likely to impact the pace of the economic recovery, we expect to continue to
see improvements in our business as we continue to learn and adapt to the ever-changing environment.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Current and Noncurrent Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries in which we operate, particularly in
developing and emerging markets. Refer to the headings “Item 1A. Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual Report on
Form 10-K for the year ended December 31, 2021. As a result, management must make numerous assumptions, which involve a significant amount of judgment, when
performing recoverability and impairment tests of current and noncurrent assets in various regions around the world.
We perform recoverability and impairment tests of current and noncurrent assets in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”). For certain assets, recoverability and/or impairment tests are required only when conditions exist that indicate the carrying value may not be recoverable. For other
assets, impairment tests are required at least annually, or more frequently if events or circumstances indicate that an asset may be impaired.
The performance of recoverability and impairment tests of current and noncurrent assets involves critical accounting estimates. These estimates require significant management
judgment, include inherent uncertainties and are often interdependent; therefore, they do not change in isolation. Factors that management must estimate include, among others,
the economic lives of the assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, the impact of any supply chain disruptions, inflation, long-term
growth rates, cost of capital, marketing spending, foreign currency exchange rates, tax rates, capital spending, proceeds from the sale of assets and customers’ financial
condition. The variability of these factors depends on a number of conditions, and thus our accounting estimates may change from period to period. These factors are even more
difficult to estimate as a result of uncertainties associated with the conflict in Ukraine and the scope, severity and duration of the global COVID-19 pandemic. The estimates we
use when performing recoverability tests of assets are consistent with those we use in our internal planning. When performing impairment tests, we estimate the fair values of
the assets using management’s best assumptions, which we believe are consistent with those a market participant would use. While pandemic-related uncertainties still exist, we
expect to see continued improvements in our business as consumers return to many of their previous work routines as well as socializing and traveling. The Company has
certain intangible and other long-lived assets that are more dependent on cash flows generated in the away-from-home channels and/or that generate cash flows in geographic
areas that are more heavily impacted by the COVID-19 pandemic and are therefore more susceptible to impairment. In addition, intangible and other long-lived assets we
acquired in recent transactions are naturally more susceptible to impairment, because they are recorded at fair value based on recent operating plans and macroeconomic
conditions at the time of acquisition. If we had used other assumptions and estimates when tests of these assets were performed, impairment charges could have resulted.
Furthermore, if management uses different assumptions in future periods, or if different conditions exist in future periods, impairment charges could result. The total future
impairment charges we may be required to record could be material.
26

-- 29 of 74 --

As of April 1, 2022, the carrying value of our investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded the fair value by $33 million, or 8 percent. Based on the length of
time and the extent to which the fair value has been less than our carrying value and our intent and ability to retain the investment for a period of time sufficient to allow for any
anticipated recovery in market value, management determined that the decline in fair value was temporary in nature. Therefore, we did not record an impairment charge related
to the investment.
Our equity method investees also perform such recoverability and impairment tests. If an impairment charge is recorded by one of our equity method investees, the Company
records its proportionate share of such charge as a reduction of equity income (loss) — net in our consolidated statement of income. However, the actual amount we record with
respect to our proportionate share of such charge may be impacted by items such as basis differences, deferred taxes and deferred gains.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales
in the beverage business may be affected by weather conditions.
Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time, we engage in buying and selling ownership interests in bottling partners and
other manufacturing operations. In addition, we periodically acquire brands and their related operations or enter into license agreements for certain brands to supplement our
beverage offerings. These items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a metric used by management to evaluate the Company’s performance because it measures demand for our products at the consumer level. The
Company’s unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its
bottling partners to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the heading “Beverage Volume”
below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or
used in finished products sold by, the Company to its bottling partners or other customers. For Costa Limited (“Costa”) non-ready-to-drink beverage products, concentrate sales
volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to
customers or consumers. Refer to the heading “Beverage Volume” below.
When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2)
changes in price, product and geographic mix; (3) foreign currency fluctuations; and (4) acquisitions and divestitures (including structural changes as defined below), as
applicable. Refer to the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling partners. The
ownership structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or syrups to our
consolidated bottling partners, we do not recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products manufactured from
the concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate revenue and concentrate
sales volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the concentrates or syrups to a
third party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an unconsolidated bottling partner as an equity
method investment, we eliminate the intercompany profit related to these transactions to the extent of our ownership interest until the equity method investee has sold finished
products manufactured from the concentrates or syrups to a third party. We typically report unit case volume when finished products manufactured from the concentrates or
syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures. Typically, structural
changes do not impact the Company’s unit case volume or concentrate sales volume on a consolidated basis or at the geographic operating segment level. We recognize unit
case volume for all sales of Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our
Bottling Investments operating segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume
related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to an acquired brand are
incremental to prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
27

-- 30 of 74 --

“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which
we derive an economic benefit when the products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to a
licensed brand in periods prior to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case volume and
concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In 2021, the Company acquired the remaining ownership interest in BA Sports Nutrition, LLC (“BodyArmor”). The impact of this acquisition has been included in acquisitions
and divestitures in our analysis of net operating revenues on a consolidated basis as well as for the North America operating segment.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, “unit case” means
a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink
beverage products, which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case equivalents) of Company
beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products
bearing Company trademarks. Also included in unit case volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system
bottlers for which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit case volume includes sales by certain
joint ventures in which the Company has an ownership interest. We believe unit case volume is one of the measures of the underlying strength of the Coca-Cola system because
it measures trends at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the Company from its bottling partners
and distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case
equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products,
concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the
Company to customers or consumers. Unit case volume and concentrate sales volume growth rates are not necessarily equal during any given period. Factors such as
seasonality, bottlers’ inventory practices, supply point changes, timing of price increases, new product introductions and changes in product mix can create differences between
unit case volume and concentrate sales volume growth rates. In addition to these items, the impact of unit case volume from certain joint ventures in which the Company has an
ownership interest, but to which the Company does not sell concentrates, syrups, source waters or powders/minerals, may give rise to differences between unit case volume and
concentrate sales volume growth rates.
Information about our volume growth worldwide and by operating segment is as follows:
Percent Change 2022 versus 2021
Three Months Ended April 1, 2022
Unit Cases 	Concentrate Sales
Worldwide 	8 % 	11 %
Europe, Middle East & Africa 	11 % 	15 %
Latin America 	9 	20
North America 	5 	3
Asia Pacific 	4 	—
Global Ventures 	23 	22
Bottling Investments 	8 	N/A
Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
Geographic and Global Ventures operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic
areas. Global Ventures operating segment data also reflects unit case volume growth for Costa retail stores.
Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the
corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
1,2,3 	4
1
2
3
28

-- 31 of 74 --

Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished
beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers and is
not based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the
first quarter of 2022 had one less day when compared to the first quarter of 2021, and the fourth quarter of 2022 will have one additional day when compared to the fourth quarter of 2021.
Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe unit case volume performance is one of the
measures of the underlying strength of the Coca-Cola system because it measures trends at the consumer level.
Unit case volume in Europe, Middle East and Africa increased 11 percent, which included 10 percent growth in Trademark Coca-Cola, 9 percent growth in sparkling flavors, 17
percent growth in hydration, sports, coffee and tea, and 18 percent growth in nutrition, juice, dairy and plant-based beverages. The operating segment reported growth in unit
case volume of 14 percent in the Europe operating unit, 9 percent in the Africa operating unit and 8 percent in the Eurasia and Middle East operating unit.
Unit case volume in Latin America increased 9 percent, which included 7 percent growth in Trademark Coca-Cola, 13 percent growth in hydration, sports, coffee and tea, 9
percent growth in sparkling flavors, and 16 percent growth in nutrition, juice, dairy and plant-based beverages. The operating segment’s volume performance included 14
percent growth in Brazil and 4 percent growth in Mexico.
Unit case volume in North America increased 5 percent, which included 6 percent growth in hydration, sports, coffee and tea, 7 percent growth in both sparkling flavors and
nutrition, juice, dairy and plant-based beverages, and 1 percent growth in Trademark Coca-Cola.
Unit case volume in Asia Pacific increased 4 percent, which included 4 percent growth in both sparkling flavors and Trademark Coca-Cola, 11 percent growth in nutrition, juice,
dairy and plant-based beverages, and 3 percent growth in hydration, sports, coffee and tea. The operating segment reported growth in unit case volume of 16 percent in the India
and Southwest Asia operating unit, 9 percent in the ASEAN and South Pacific operating unit, and 4 percent in the Japan and South Korea operating unit, partially offset by a
decline in unit case volume of 3 percent in the Greater China and Mongolia operating unit.
Unit case volume for Global Ventures increased 23 percent, driven by 32 percent growth in hydration, sports, coffee and tea, growth in energy drinks and even performance in
nutrition, juice, dairy and plant-based beverages.
Unit case volume for Bottling Investments increased 8 percent, which primarily reflects growth in the Philippines and India.
Concentrate Sales Volume
During the three months ended April 1, 2022, worldwide concentrate sales volume increased 11 percent and unit case volume increased 8 percent compared to the three months
ended April 2, 2021. Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the number of days.
Conversely, unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The first quarter of 2022
had one less day when compared to the first quarter of 2021, which contributed to the differences between concentrate sales volume and unit case volume growth rates on a
consolidated basis and for the individual operating segments during the three months ended April 1, 2022. In addition, for the Europe, Middle East and Africa and Latin
America operating segments, the differences between concentrate sales volume and unit case volume growth rates during the three months ended April 1, 2022 were impacted
by the timing of concentrate shipments, as certain bottlers adjusted inventory levels in an effort to manage through near-term supply chain disruptions as we enter the peak
selling season in many markets. The difference between concentrate sales volume and unit case volume growth for the Asia Pacific operating segment was partially due to the
resurgence of COVID-19 and the related lockdowns in China. We expect the differences between concentrate sales volume and unit case volume growth rates to lessen over the
remainder of the year.
4
29

-- 32 of 74 --

Net Operating Revenues
During the three months ended April 1, 2022, net operating revenues were $10,491 million, compared to $9,020 million during the three months ended April 2, 2021, an
increase of $1,471 million, or 16 percent.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2022 versus 2021
Volume
Price, Product &
Geographic Mix
Foreign Currency
Fluctuations
Acquisitions &
Divestitures 	Total
Consolidated 	11 % 	7 % 	(4) % 	3 % 	16 %
Europe, Middle East & Africa 	15 % 	6 % 	(9) % 	— % 	13 %
Latin America 	20 	19 	(6) 	— 	34
North America 	3 	11 	— 	8 	22
Asia Pacific 	— 	6 	(5) 	— 	1
Global Ventures 	22 	12 	(6) 	— 	28
Bottling Investments 	7 	5 	(5) 	— 	8
Note: Certain rows may not add due to rounding.
Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments and our Global Ventures
operating segment (expressed in unit case equivalents) after considering the impact of acquisitions and divestitures. For our Bottling Investments operating segment, this represents the percent
change in net operating revenues attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the
corresponding periods after considering the impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers
only after considering the impact of structural changes, if any. Refer to the heading “Beverage Volume” above.
Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
“Price, product and geographic mix” refers to the change in net operating revenues caused by factors such as price changes, the mix of products and packages sold, and the mix
of channels and geographic territories where the sales occurred. The impact of price, product and geographic mix is calculated by subtracting the change in net operating
revenues resulting from volume increases or decreases, changes in foreign currency exchange rates, and acquisitions and divestitures from the total change in net operating
revenues. Management believes that providing investors with price, product and geographic mix enhances their understanding about the combined impact that the following
items had on the Company’s net operating revenues: (1) pricing actions taken by the Company and, where applicable, our bottling partners; (2) changes in the mix of products
and packages sold; (3) changes in the mix of channels where products were sold; and (4) changes in the mix of geographic territories where products were sold. Management
uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Price, product and geographic mix had a 7 percent favorable impact on our consolidated net operating revenues. Price, product and geographic mix was impacted by a variety of
factors and events including, but not limited to, the following:
• Europe, Middle East and Africa — favorable channel and package mix and favorable pricing initiatives, including inflationary pricing in Turkey, partially offset by
unfavorable geographic mix;
• Latin America — favorable pricing initiatives, including inflationary pricing in Argentina, along with favorable channel and package mix;
• North America — favorable pricing initiatives, including a benefit resulting from the timing of price increases in the prior year, and favorable channel and product mix;
• Asia Pacific — favorable pricing initiatives along with favorable channel, package and geographic mix;
• Global Ventures — favorable channel mix, primarily due to the timing of Costa retail store reopenings in the United Kingdom in the prior year, and favorable product mix;
and
• Bottling Investments — favorable pricing initiatives.
1 	2
1
2
30

-- 33 of 74 --

The favorable channel and package mix for the three months ended April 1, 2022 in all applicable operating segments was primarily a result of the continued recovery in away-
from-home channels in many markets in the current year and the impact of shelter-in-place and social distancing requirements in the prior year.
Fluctuations in foreign currency exchange rates decreased our consolidated net operating revenues by 4 percent. This unfavorable impact was primarily due to a stronger U.S.
dollar compared to certain foreign currencies, including the Turkish lira, euro, Japanese yen and Philippine peso, which had an unfavorable impact on our Europe, Middle East
and Africa, Asia Pacific and Bottling Investments operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was partially
offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Chinese yuan, which had a favorable impact on our Asia Pacific
operating segment. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The
impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we
removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that
quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their understanding
of the Company’s net operating revenue performance by improving their ability to compare our period-to-period results. Management considers the impact of acquisitions and
divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for additional
information related to acquisitions and divestitures.
Net operating revenue growth rates are impacted by sales volume; price, product and geographic mix; foreign currency fluctuations; and acquisitions and divestitures. The size
and timing of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency
fluctuations will have an unfavorable impact on our full year 2022 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information
related to the profitability of our business prior to considering all of the operating costs incurred. Management uses this measure in making financial, operating and planning
decisions and in evaluating the Company’s performance.
Our gross profit margin decreased to 61.0 percent for the three months ended April 1, 2022, compared to 61.1 percent for the three months ended April 2, 2021. This decrease
was primarily due to the unfavorable impact of foreign currency exchange rate fluctuations, the impact of increased commodity and transportation costs, and the acquisition of
BodyArmor. These unfavorable impacts were partially offset by the impact of favorable pricing initiatives as well as favorable channel and package mix. We expect commodity
and transportation costs to continue to increase in 2022, and we will continue to proactively take actions in an effort to mitigate the impact of these incremental costs.
Selling, General and Administrative Expenses
The following table sets forth the components of selling, general and administrative expenses (in millions):
Three Months Ended
April 1,
2022
April 2,
2021
Selling and distribution expenses 	$ 	655 $ 	618
Advertising expenses 	980 	901
Stock-based compensation expense 	87 	58
Other operating expenses 	1,245 	1,092
Selling, general and administrative expenses 	$ 	2,967 $ 	2,669
During the three months ended April 1, 2022, selling, general and administrative expenses increased $298 million, or 11 percent, versus the prior year. The increase was due to
increased marketing spending, higher annual incentive and stock-based compensation expense, and increased selling and distribution expenses. The increase in annual incentive
and stock-based compensation expense was due to a more favorable outlook for our financial performance in the current year. The increase in selling and distribution expenses
was primarily due to the continued recovery from the COVID-19 pandemic. During the three months ended April 1, 2022, foreign currency exchange rate fluctuations
decreased selling, general and administrative expenses by 3 percent.
31

-- 34 of 74 --

As of April 1, 2022, we had $517 million of total unrecognized compensation cost related to nonvested stock-based compensation awards granted under our plans, which we
expect to recognize over a weighted-average period of 2.2 years as stock-based compensation expense. This expected cost does not include the impact of any future stock-based
compensation awards.
Other Operating Charges
Other operating charges incurred by operating segment and Corporate were as follows (in millions):
Three Months Ended
April 1,
2022 April 2,
2021
Europe, Middle East & Africa 	$ 	(1) $ 	50
Latin America 	— 	11
North America 	(17) 	12
Asia Pacific 	— 	13
Global Ventures 	— 	—
Bottling Investments 	— 	—
Corporate 	46 	38
Total 	$ 	28 $ 	124
During the three months ended April 1, 2022, the Company recorded other operating charges of $28 million. These charges primarily consisted of $22 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, $10 million related to the
Company’s productivity and reinvestment program and $2 million related to the restructuring of our manufacturing operations in the United States. These charges were partially
offset by a net gain of $5 million, which included the reimbursement of distributor termination fees for BodyArmor recorded in the prior year partially offset by various
transition and transaction costs, employee retention costs and the amortization of noncompete agreements, and income of $1 million related to the Company’s strategic
realignment initiatives primarily as a result of a revision to estimated severance costs accrued in the prior year.
During the three months ended April 2, 2021, the Company recorded other operating charges of $124 million. These charges primarily consisted of $93 million related to the
Company’s strategic realignment initiatives and $18 million related to the Company’s productivity and reinvestment program. In addition, other operating charges included $4
million related to the remeasurement of our contingent consideration liability to fair value in conjunction with the fairlife acquisition and $9 million related to tax litigation
expense.
Refer to Note 8 of Notes to Consolidated Financial Statements for additional information related to the tax litigation. Refer to Note 12 of Notes to Consolidated Financial
Statements for additional information on the Company’s productivity and reinvestment program. Refer to Note 16 of Notes to Consolidated Financial Statements for the impact
these charges had on our operating segments and Corporate.
Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended
April 1,
2022
April 2,
2021
Europe, Middle East & Africa 	29.6 % 	30.1 %
Latin America 	22.3 	20.3
North America 	31.0 	29.1
Asia Pacific 	19.5 	25.2
Global Ventures 	1.5 	1.0
Bottling Investments 	5.7 	5.2
Corporate 	(9.6) 	(10.9)
Total 	100.0 % 	100.0 %
32

-- 35 of 74 --

Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful
information related to the profitability of our business after considering all of the operating costs incurred. Management uses this measure in making financial, operating and
planning decisions and in evaluating the Company’s performance.
Information about our operating margin on a consolidated basis and by operating segment and Corporate is as follows:
Three Months Ended
April 1,
2022
April 2,
2021
Consolidated 	32.5 % 	30.2 %
Europe, Middle East & Africa 	60.6 % 	56.1 %
Latin America 	62.6 	60.7
North America 	29.4 	27.0
Asia Pacific 	53.9 	55.6
Global Ventures 	6.9 	4.6
Bottling Investments 	9.5 	7.4
Corporate 	* 	*
* Calculation is not meaningful.
During the three months ended April 1, 2022, operating income was $3,405 million, compared to $2,722 million during the three months ended April 2, 2021, an increase of
$683 million, or 25 percent. The increase was driven by concentrate sales volume growth of 11 percent, favorable channel and package mix, and lower other operating charges,
partially offset by an unfavorable foreign currency exchange rate impact and higher selling, general and administrative expenses.
During the three months ended April 1, 2022, fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 6 percent due to a
stronger U.S. dollar compared to certain foreign currencies, including the Japanese yen, Turkish lira, euro and Argentine peso, which had an unfavorable impact on our Asia
Pacific, Europe, Middle East and Africa, and Latin America operating segments. The unfavorable impact of a stronger U.S. dollar compared to the currencies listed above was
partially offset by the impact of a weaker U.S. dollar compared to certain other foreign currencies, including the Chinese yuan, which had a favorable impact on our Asia Pacific
operating segment. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
The Europe, Middle East and Africa operating segment reported operating income of $1,007 million and $820 million for the three months ended April 1, 2022 and April 2,
2021, respectively. The increase in operating income was primarily driven by concentrate sales volume growth of 15 percent, favorable channel and package mix, and lower
other operating charges, partially offset by an unfavorable foreign currency exchange rate impact of 11 percent.
Latin America reported operating income of $760 million and $552 million for the three months ended April 1, 2022 and April 2, 2021, respectively. The increase in operating
income was primarily driven by concentrate sales volume growth of 20 percent, favorable pricing initiatives, and lower other operating charges, partially offset by increased
marketing spending and an unfavorable foreign currency exchange rate impact of 7 percent.
Operating income for North America for the three months ended April 1, 2022 and April 2, 2021 was $1,056 million and $792 million, respectively. The increase in operating
income was primarily driven by concentrate sales volume growth of 3 percent, favorable pricing initiatives, favorable channel and product mix, and lower other operating
charges, partially offset by higher annual incentive expense and increased marketing spending.
Asia Pacific’s operating income for the three months ended April 1, 2022 and April 2, 2021 was $664 million and $686 million, respectively. The decrease in operating income
was primarily driven by an unfavorable foreign currency exchange rate impact of 5 percent and increased marketing spending, partially offset by favorable pricing, channel and
package mix along with lower other operating charges.
Global Ventures’ operating income for the three months ended April 1, 2022 and April 2, 2021 was $51 million and $26 million, respectively. The increase in operating income
was primarily driven by net operating revenue growth as a result of the timing of Costa retail store reopenings in the United Kingdom in the prior year, partially offset by higher
selling and distribution expenses, increased marketing spending and an unfavorable foreign currency exchange rate impact of 5 percent.
Bottling Investments’ operating income for the three months ended April 1, 2022 and April 2, 2021 was $193 million and $141 million, respectively. The increase in operating
income was primarily driven by volume growth of 7 percent, favorable pricing initiatives and effective cost management, partially offset by an unfavorable foreign currency
exchange rate impact of 7 percent.
33

-- 36 of 74 --

Corporate’s operating loss for the three months ended April 1, 2022 and April 2, 2021 was $326 million and $295 million, respectively. Operating loss in 2022 increased
primarily as a result of higher annual incentive and stock-based compensation expense as well as higher other operating charges.
Based on current spot rates and our hedging coverage in place, we expect foreign currency fluctuations will have an unfavorable impact on our full year 2022 operating income.
Interest Income
During the three months ended April 1, 2022, interest income was $78 million, compared to $66 million during the three months ended April 2, 2021, an increase of
$12 million, or 20 percent. The increase was primarily driven by higher returns in certain of our international locations.
Interest Expense
During the three months ended April 1, 2022, interest expense was $182 million, compared to $442 million during the three months ended April 2, 2021, a decrease of
$260 million, or 59 percent. The decrease was primarily due to certain hedging activities and charges of $58 million in the prior year associated with the extinguishment of
long-term debt.
Equity Income (Loss) — Net
During the three months ended April 1, 2022, equity income was $262 million, compared to equity income of $279 million during the three months ended April 2, 2021, a
decrease of $17 million, or 6 percent. The decrease was primarily due to a
$32 million reduction in net gains resulting from the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method
investees and an unfavorable foreign currency exchange rate impact. These unfavorable impacts were partially offset by more favorable operating results reported by several of
our equity method investees in the current year.
Other Income (Loss) — Net
Other income (loss) — net includes, among other things, dividend income; gains and losses related to the disposal of property, plant and equipment; gains and losses related to
acquisitions and divestitures; non-service cost components of net periodic benefit cost or income for pension and other postretirement benefit plans; other charges and credits
related to pension and other postretirement benefit plans; realized and unrealized gains and losses on equity securities and trading debt securities; realized gains and losses on
available-for-sale debt securities; other-than-temporary impairment charges; and net foreign currency exchange gains and losses. The foreign currency exchange gains and
losses are primarily the result of the remeasurement of monetary assets and liabilities from certain currencies into functional currencies. The effects of the remeasurement of
these assets and liabilities are partially offset by the impact of our economic hedging program for certain exposures on our consolidated balance sheet. Refer to Note 6 of Notes
to Consolidated Financial Statements.
During the three months ended April 1, 2022, other income (loss) — net was a loss of $105 million. The Company recognized a net loss of $104 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities, net foreign currency
exchange losses of $73 million and a net loss of $24 million as a result of one of our equity method investees issuing additional shares of its stock. Additionally, other income
(loss) — net included income of $70 million related to the non-service cost components of net periodic benefit income and dividend income of $12 million.
During the three months ended April 2, 2021, other income (loss) — net was income of $138 million. The Company recognized a net gain of $133 million related to realized
and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also
recorded pension settlement charges of $54 million related to its strategic realignment initiatives. Other income (loss) — net also included income of $60 million related to the
non-service cost components of net periodic benefit income, $10 million of dividend income and net foreign currency exchange losses of $9 million. None of the other items
included in other income (loss) — net was individually significant.
Refer to Note 4 of Notes to Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 6 of Notes to Consolidated Financial
Statements for additional information on economic hedging activities. Refer to Note 13 of Notes to Consolidated Financial Statements for additional information on net periodic
benefit income. Refer to Note 15 of Notes to Consolidated Financial Statements for additional information on one of our equity method investees issuing additional shares of its
stock. Refer to Note 16 of Notes to Consolidated Financial Statements for the impact that certain of these items had on our operating segments and Corporate.
34

-- 37 of 74 --

Income Taxes
The Company recorded income taxes of $665 million (19.2 percent effective tax rate) and $508 million (18.4 percent effective tax rate) during the three months ended April 1,
2022 and April 2, 2021, respectively.
The Company’s effective tax rates for the three months ended April 1, 2022 and April 2, 2021 vary from the statutory U.S. federal income tax rate of 21.0 percent primarily due
to the tax impact of significant operating and nonoperating items, as described in Note 11 of Notes to Consolidated Financial Statements, along with the tax benefits of having
significant earnings generated outside the United States and significant earnings generated in investments accounted for under the equity method, both of which are generally
taxed at rates lower than the statutory U.S. rate.
On November 18, 2020, the U.S. Tax Court (“Tax Court”) issued an opinion (“Opinion”) regarding the Company’s 2015 litigation with the U.S. Internal Revenue Service
(“IRS”) involving transfer pricing tax adjustments in which the Tax Court predominantly sided with the IRS. The Company strongly disagrees with the Opinion and intends to
vigorously defend its position. Refer to Note 8 of Notes to Consolidated Financial Statements for additional information on the litigation.
At the end of each quarter, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items, our
best estimate of operating results and foreign currency exchange rates. Based on enacted tax laws, including our current interpretation of recently issued regulations, the
Company’s effective tax rate in 2022 is expected to be 19.5 percent before considering the potential impact of any significant operating and nonoperating items that may affect
our effective tax rate. This rate does not include the impact of the ongoing tax litigation with the IRS, if the Company were not to prevail.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
We believe our ability to generate cash flows from operating activities is one of the fundamental strengths of our business. Refer to the heading “Cash Flows from Operating
Activities” below. The Company does not typically raise capital through the issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase
our return on shareowners’ equity. Refer to the heading “Cash Flows from Financing Activities” below. We have a history of borrowing funds both domestically and
internationally at reasonable interest rates, and we expect to be able to continue to borrow funds at reasonable rates over the long term. Our debt financing also includes the use
of a commercial paper program. We currently have the ability to borrow funds in this market at levels that are consistent with our debt financing strategy and, and we expect to
continue to be able to do so in the future.
The Company regularly reviews its optimal mix of short-term and long-term debt. The Company’s cash, cash equivalents, short-term investments and marketable securities
totaled $10.4 billion as of April 1, 2022. In addition to these funds, our commercial paper program, and our ability to issue long-term debt, we had $7.8 billion in unused backup
lines of credit for general corporate purposes as of April 1, 2022. These backup lines of credit expire at various times from 2022 through 2027.
Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow our dividend payment, enhancing our beverage
portfolio and capabilities through opportunistic and disciplined acquisitions, and using excess cash to repurchase shares over time. We currently expect 2022 capital
expenditures to be approximately $1.5 billion. During 2022, we also expect to repurchase approximately $500 million of shares in addition to repurchasing shares equivalent to
the proceeds from the issuances of stock under our stock-based compensation plans.
We are currently in litigation with the IRS for tax years 2007 through 2009. On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the
IRS; however, a final decision is still pending and the timing of such decision is not currently known. The Company strongly disagrees with the IRS’ positions and the portions
of the Opinion affirming such positions and intends to vigorously defend our positions utilizing every available avenue of appeal. While the Company believes that it is more
likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that all, or some portion of, the adjustments proposed by the IRS and sustained by the
Tax Court could ultimately be upheld. In the event that all of the adjustments proposed by the IRS are ultimately upheld for tax years 2007 through 2009 and the IRS, with the
consent of the federal courts, were to decide to apply the underlying methodology (“Tax Court Methodology”) to the subsequent years up to and including 2021, the Company
currently estimates that the potential aggregate incremental tax and interest liability could be approximately $13 billion as of December 31, 2021. Additional income tax and
interest would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the continued application
of the Tax Court Methodology for the three months ended April 1, 2022 would increase the potential aggregate incremental tax and interest liability by approximately
$250 million. Once the Tax Court renders a final decision, the Company will have 90 days to file a notice of appeal and pay the portion of the potential aggregate incremental
tax and interest liability related to the 2007 through 2009 tax years, which we currently estimate to be approximately $5.0 billion (including interest accrued through April 1,
2022), plus any additional interest accrued through the time of payment. Refer to Note 8 of Notes to Consolidated Financial Statements for additional information on the tax
litigation.
35

-- 38 of 74 --

While we believe it is more likely than not that we will prevail in the tax litigation discussed above, we are confident that, between our ability to generate cash flows from
operating activities and our ability to borrow funds at reasonable interest rates, we can manage the range of possible outcomes in the final resolution of the matter.
Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be sufficient to fund our operating activities and
cash commitments for investing and financing activities for the foreseeable future.
Cash Flows from Operating Activities
As part of our continued efforts to improve our working capital efficiency, we have worked with our suppliers over the past several years to revisit terms and conditions,
including the extension of payment terms. Our current payment terms with the majority of our suppliers are 120 days. Additionally, two global financial institutions offer a
voluntary supply chain finance (“SCF”) program which enables our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions
on a non-recourse basis at a rate that leverages our credit rating and thus may be more beneficial to them. The SCF program is available to suppliers of goods and services
included in cost of goods sold as well as suppliers of goods and services included in selling, general and administrative expenses in our consolidated statement of income. The
Company and our suppliers agree on contractual terms for the goods and services we procure, including prices, quantities and payment terms, regardless of whether the supplier
elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to the Company and issue the associated invoices to the Company based on the
agreed-upon contractual terms. Then, if they are participating in the SCF program, our suppliers, at their sole discretion, determine which invoices, if any, they want to sell to
the financial institutions. Our suppliers’ voluntary inclusion of invoices in the SCF program has no bearing on our payment terms. No guarantees are provided by the Company
or any of our subsidiaries under the SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct financial
relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers that elected to participate in the SCF program are included
in the line item accounts payable and accrued expenses in our consolidated balance sheet. All activity related to amounts due to suppliers that elected to participate in the SCF
program is reflected within the operating activities section of our consolidated statement of cash flows. We have been informed by the financial institutions that as of April 1,
2022 and December 31, 2021, suppliers had elected to sell $876 million and $882 million, respectively, of our outstanding payment obligations to the financial institutions. The
amounts settled through the SCF program were $882 million and $705 million during the three months ended April 1, 2022 and April 2, 2021, respectively. We do not believe
there is a risk that our payment terms will be shortened in the near future, and we do not currently expect our net cash provided by operating activities to be significantly
impacted by additional extensions of payment terms in the foreseeable future.
The Company has a trade accounts receivable factoring program in certain countries. Under this program, we can elect to sell trade accounts receivables to unaffiliated financial
institutions at a discount. In these factoring arrangements, for ease of administration, the Company collects customer payments related to the factored receivables and remits
those payments to the financial institutions. The Company sold $1,597 million and $1,309 million of trade accounts receivables under this program during the three months
ended April 1, 2022 and April 2, 2021, respectively, and the costs of factoring such receivables were not material. The cash received from the financial institutions is reflected
within the operating activities section of our consolidated statement of cash flows.
Net cash provided by operating activities during the three months ended April 1, 2022 and April 2, 2021 was $623 million and $1,636 million, respectively, a decrease of
$1,013 million, or 62 percent. This decrease was primarily driven by higher annual incentive payments in 2022, higher marketing payments resulting from year-end accruals,
lower benefits from our trade accounts receivable factoring program in the current year, and an unfavorable impact due to foreign currency exchange rate fluctuations. These
items were partially offset by increased operating income, lower payments related to our strategic realignment initiatives and lower tax payments.
Cash Flows from Investing Activities
Net cash provided by investing activities during the three months ended April 1, 2022 was $146 million, and net cash used in investing activities during the three months ended
April 2, 2021 was $281 million.
Purchases of Investments and Proceeds from Disposals of Investments
During the three months ended April 1, 2022, purchases of investments were $835 million and proceeds from disposals of investments were $1,323 million, resulting in a net
cash inflow of $488 million. During the three months ended April 2, 2021, purchases of investments were $1,466 million and proceeds from disposals of investments were
$1,375 million, resulting in a net cash outflow of $91 million. This activity primarily represents the purchases of, and proceeds from the disposals of, investments in marketable
securities and short-term investments that were made as part of the Company’s overall cash management strategy. Also included in this activity are purchases of, and proceeds
from the disposals of, investments held by our captive insurance companies. Refer to Note 4 of Notes to Consolidated Financial Statements for additional information.
36

-- 39 of 74 --

Acquisitions of Businesses, Equity Method Investments and Nonmarketable Securities
During the three months ended April 1, 2022 and April 2, 2021, the Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled
$5 million and $4 million, respectively.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the three months ended April 1, 2022, proceeds from disposals of businesses, equity method investments and nonmarketable securities were $218 million, which
primarily related to the sale of our ownership interest in one of our equity method investments. During the three months ended April 2, 2021, proceeds from disposals of
businesses, equity method investments and nonmarketable securities were $2 million. Refer to Note 2 of Notes to Consolidated Financial Statements for additional information.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment during the three months ended April 1, 2022 and April 2, 2021 were $217 million and $216 million, respectively.
Cash Flows from Financing Activities
Net cash used in financing activities during the three months ended April 1, 2022 was $2,975 million, and net cash provided by financing activities during the three months
ended April 2, 2021 was $364 million.
Debt Financing
Issuances and payments of debt included both short-term and long-term financing activities. During the three months ended April 1, 2022, the Company had issuances of debt
of $1,052 million, which included $1,026 million of net issuances of commercial paper and short-term debt with maturities of 90 days or less, $5 million of issuances of
commercial paper and short-term debt with maturities greater than 90 days, and long-term debt issuances of $21 million, net of related discounts and issuance costs.
The Company made payments of debt of $1,045 million during the three months ended April 1, 2022, which included $750 million of payments of commercial paper and short-
term debt with maturities greater than 90 days and payments of long-term debt of $295 million.
During the three months ended April 1, 2022, the Company retired upon maturity U.S. dollar-denominated debentures of $288 million.
Issuances of Stock
During the three months ended April 1, 2022, the Company received cash proceeds from issuances of stock of $449 million, an increase of $266 million when compared to cash
proceeds from issuances of stock of $183 million during the three months ended April 2, 2021. The issuances of stock during the three months ended April 1, 2022 and April 2,
2021 were related to the exercise of stock options by employees.
Share Repurchases
During the three months ended April 1, 2022, the total cash outflow for treasury stock purchases was $546 million. The Company repurchased 7.7 million shares of common
stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $61.48 per share, for a total cost of $471
million. In addition to shares repurchased, the Company’s treasury stock activity also includes shares surrendered to the Company to pay the exercise price and/or to satisfy tax
withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees. The net impact
of the Company’s issuances of stock and share repurchases during the three months ended April 1, 2022 resulted in a net cash outflow of $97 million. During 2022, we expect to
repurchase approximately $500 million of shares in addition to repurchasing shares equivalent to the proceeds from the issuances of stock under our stock-based compensation
plans.
Dividends
During the three months ended April 1, 2022 and April 2, 2021, the Company paid dividends of $1,906 million and $1,810 million, respectively.
Our Board of Directors approved the Company’s regular quarterly dividend of $0.44 per share at its April 2022 meeting. This dividend is payable on July 1, 2022 to
shareowners of record as of the close of business on June 15, 2022.
37

-- 40 of 74 --

Other Financing Activities
During the three months ended April 1, 2022 and April 2, 2021, the total cash outflow for other financing activities was $979 million and $449 million, respectively. The
activity during the three months ended April 1, 2022 included the payment of $540 million of the purchase price for BodyArmor, which was originally held back related to
indemnification obligations.
Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental actions. We closely monitor our operations in each
country and seek to adopt appropriate strategies that are responsive to changing economic and political environments as well as to fluctuations in currencies.
Due to the geographic diversity of our operations, weakness in some currencies may be offset by strength in others. Our foreign currency management program is designed to
mitigate, over time, a portion of the potentially unfavorable impact of exchange rate changes on our net income and earnings per share. Taking into account the effects of our
hedging activities, the impact of fluctuations in foreign currency exchange rates decreased our operating income for the three months ended April 1, 2022 by 6 percent.
Based on current spot rates and our hedging coverage in place, we expect foreign currency fluctuations will have an unfavorable impact on operating income and cash flows
from operating activities through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the
effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as
amended (“Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded
that the Company’s disclosure controls and procedures were effective as of April 1, 2022.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the quarter ended April 1, 2022 that have materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, “Item 3. Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31,
2021. The following updates and restates the description of the previously reported U.S. Federal Income Tax Dispute matter.
U.S. Federal Income Tax Dispute
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the U.S. Internal Revenue Service (“IRS”) seeking approximately $3.3 billion
of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from
certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in a closing agreement resolving that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances
38

-- 41 of 74 --

or relevant federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax
calculation methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the
Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by approximately $138
million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid
by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would
become payable to the Company in accordance with the Opinion. The Tax Court reserved ruling on the effect of Brazilian legal restrictions on the payment of royalties by the
Company’s licensee in Brazil until after the Tax Court issues its opinion in the separate case of 3M Co. & Subs. v. Commissioner, T.C. Docket No. 5816-13 (filed March 11,
2013). Once the Tax Court issues its opinion in 3M Co. & Subs. v. Commissioner, the Company expects the Tax Court thereafter to render another opinion, and ultimately a
final decision, in the Company’s case.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on appeal
and vigorously defend its position.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors and we reviewed and considered relevant laws, rules, and regulations,
including, but not limited to, the Opinion and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-founded legal
claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not the Company’s
tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the methodology asserted by
the IRS and affirmed in the Opinion (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on the required probability
analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we
recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment
applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in
accordance with the Opinion and the Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of April 1, 2022. However, we
updated our calculation of the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of the application of
the required probability analysis to these updated calculations and the accrual of interest through the current reporting period, we updated our tax reserve as of April 1, 2022 to
$410 million.
39

-- 42 of 74 --

While the Company strongly disagrees with the IRS’ positions and the portions of the Opinion affirming such positions, it is possible that some portion or all of the adjustment
proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would likely be subject to significant additional liabilities for tax
years 2007 through 2009, and potentially also for subsequent years, which could have a material adverse impact on the Company’s financial position, results of operations and
cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinion, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to subsequent years, with consent of the
federal courts. This impact would include taxes and interest accrued through December 31, 2021 for the 2007 through 2009 litigated tax years and for subsequent tax years from
2010 through 2021. The calculations incorporated the estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and
Jobs Act. The Company estimates that the potential aggregate incremental tax and interest liability could be approximately $13 billion as of December 31, 2021. Additional
income tax and interest would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the
continued application of the Tax Court Methodology for the three months ended April 1, 2022 would increase the potential aggregate incremental tax and interest liability by
approximately $250 million. Additionally, we currently project the continued application of the Tax Court Methodology in future years, assuming similar facts and
circumstances as of December 31, 2021, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by approximately 3.5 percent.
The Company does not know when the Tax Court will issue its opinion regarding the effect of Brazilian legal restrictions on the payment of royalties by the Company’s licensee
in Brazil for the 2007 through 2009 tax years. After the Tax Court issues its opinion on the Company’s Brazilian licensee, the Company and the IRS will be provided time to
agree on the tax impact, if any, of both opinions, after which the Tax Court would render a final decision in the case. The Company will have 90 days thereafter to file a notice
of appeal to the U.S. Court of Appeals for the Eleventh Circuit and pay the tax liability and interest related to the 2007 through 2009 tax years. The Company currently estimates
that the payment to be made at that time related to the 2007 through 2009 tax years, which is included in the above estimate of the potential aggregate incremental tax and
interest liability, would be approximately $5.0 billion (including interest accrued through April 1, 2022), plus any additional interest accrued through the time of payment. Some
or all of this amount would be refunded if the Company were to prevail on appeal.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form
10-K for the year ended December 31, 2021, which could materially affect our business, financial condition or future results. The risks described in this report and in our
Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be
immaterial, could also materially adversely affect our business, financial condition or future results.
The conflict between Russia and Ukraine has had, and may continue to have, an adverse effect on our business and results of operations.
The conflict between Russia and Ukraine has adversely affected, and we expect could continue to adversely affect, our business and results of operations. On March 8, 2022, the
Company announced the suspension of its business in Russia. In addition, while we have maintained our operations in Ukraine to the extent possible, our business in Ukraine
has been disrupted due to the conflict. Although we currently do not anticipate that the suspension of our operations in Russia or the disruptions in Ukraine will have a material
impact on our results of operations, if prolonged, the conflict could result in impairment charges. The broader consequences of the conflict on our business as well as the global
economy are highly uncertain and may include further governmental sanctions, embargoes, regional instability and geopolitical shifts; shortages of and/or increased costs for
transportation, energy and raw materials; disruptions to the global economy, including repercussions on national economies where we operate; risks related to state-sponsored
espionage, ransomware or cyberterrorism; potential retaliatory actions by the Russian government against companies, including us, as a result of the suspension of services in
Russia; and increased tensions between the United States and other countries in which we operate. We may also face negative publicity based on actions we take as a result of
the conflict, which could damage our brand image and corporate reputation.
The conflict in Ukraine may also heighten or affect other risks discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December
31, 2021, any of which could materially and adversely affect our business and results of operations. Such risks include, but are not limited to, adverse effects on general
economic and political conditions, including inflation, supply chain disruptions and lower consumer spending; disruptions to our information systems, including through
network failures, malicious or disruptive software, or cyberattacks by hackers, criminal groups or nation-state organizations; trade disruptions; rising fuel and/or ingredient
costs; our exposure to foreign currency exchange rate fluctuations; and constraints, volatility or disruption in the financial markets.
40

-- 43 of 74 --

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended April 1, 2022 by the Company or any
“affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended (“Exchange Act”):
Period
Total Number
of Shares
Purchased
Average
Price Paid
Per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plan
Maximum Number
of Shares That May
Yet Be Purchased
Under Publicly
Announced Plans
January 1, 2022 through January 28, 2022 	51 $ 	55.40 	— 	161,029,667
January 29, 2022 through February 25, 2022 	3,718,743 	61.01 	2,658,700 	158,370,967
February 26, 2022 through April 1, 2022 	5,927,299 	61.87 	5,009,617 	153,361,350
Total 	9,646,093 $ 	61.54 	7,668,317
The total number of shares purchased includes: (i) shares purchased, if any, pursuant to the 2012 Plan described in footnote 2 below and (ii) shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with so-called stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees.
On October 18, 2012, the Company publicly announced that our Board of Directors had authorized a plan (“2012 Plan”) for the Company to purchase up to 500 million shares of our common
stock. This column discloses the number of shares purchased pursuant to the 2012 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading
plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
On February 21, 2019, the Company publicly announced that our Board of Directors had authorized a new plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our
common stock following the completion of the 2012 Plan. This column discloses the number of shares available for purchase under the 2012 Plan and the number of shares authorized for
purchase under the 2019 Plan.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to
provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants
and conditions by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the
other parties to the applicable agreement and:
• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be
inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not
necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
• were made only as of the date of the applicable agreement, or such other date or dates as may be specified in the agreement, and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the date they were made or at any other time.
Additional information about the Company may be found elsewhere in this report and the Company’s other public filings, which are available without charge through the
Securities and Exchange Commission’s website at http://www.sec.gov.
1 	2 	3
1
2
3
41

-- 44 of 74 --

EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company’s Current, Quarterly and Annual Reports are filed with the Securities and Exchange
Commission (“SEC”) under File No. 001-02217; and Coca-Cola Refreshments USA, LLC’s (formerly known as Coca-Cola Refreshments USA, Inc. and Coca-Cola
Enterprises Inc.) Current, Quarterly and Annual Reports are filed with the SEC under File No. 001-09300).
3.1 	Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27, 2012 — incorporated herein by reference to
Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2012.
3.2 	By-Laws of the Company, as amended and restated through April 22, 2020 — incorporated herein by reference to Exhibit 3.2 to the Company’s Quarterly
Report on Form 10-Q for the quarter ended March 27, 2020.
4.1 	As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of long-term debt of the Company or
consolidated subsidiaries under which the total amount of securities authorized does not exceed 10 percent of the total assets of the Company and its consolidated
subsidiaries. The Company agrees to furnish to the SEC, upon request, a copy of any omitted instrument.
4.2 	Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers
Trust Company, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.3 	First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and
Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the
Company’s Current Report on
Form 8-K filed on May 25, 2017.
4.4 	Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the
Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3
of the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.5 	Form of Note for 1.875% Notes due 2026 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 19, 2014.
4.6 	Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company’s Registration Statement on Form 8-A filed on
March 6, 2015.
4.7 	Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company’s Registration Statement on Form 8-A filed on
March 6, 2015.
4.8 	Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 2, 2016.
4.9 	Form of Note for 0.500% Notes due 2024 — incorporated herein by reference to Exhibit 4.6 to the Company’s Registration Statement on Form 8-A filed on
March 9, 2017.
4.10 	Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.11 	Form of Note for 0.750% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.12 	Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.13 	Form of Note for 1.750% Notes due 2024 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September
9, 2019.
4.14 	Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September
9, 2019.
4.15 	Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.16 	Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.17 	Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.18 	Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.19 	Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 4,
2020.
4.20 	Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 4,
2020.
42

-- 45 of 74 --

4.21 	Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 4,
2020.
4.22 	Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on May 4,
2020.
4.23 	Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on May 4,
2020.
4.24 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.25 	Form of Note for 0.375% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.26 	Form of Note for 0.800% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.27 	Form of Note for 1.000% Notes due 2028 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.28 	Form of Note for 1.375% Notes due 2031 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.29 	Form of Note for 2.500% Notes due 2051 — incorporated herein by reference to Exhibit 4.9 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.30 	Form of Note for 1.500% Notes due 2028 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.31 	Form of Note for 2.000% Notes due 2031 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.32 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.33 	Form of Note for 0.500% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.34 	Form of Note for 1.000% Notes due 2041 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.35 	Form of Note for 2.250% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 5,
2021.
4.36 	Form of Note for 2.875% Notes due 2041 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 5,
2021.
4.37 	Form of Note for 3.000% Notes due 2051 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 5,
2021.
4.38 	Form of Note for 0.950% Notes due 2036 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 6,
2021.
4.39 	Form of Note for 0.400% Notes due 2030 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 17,
2021.
4.40 	Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated
herein by reference to Exhibit 4.1 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-K dated July 30, 1991.
4.41 	First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and
Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.’s Current Report
on Form 8-K dated January 29, 1992.
4.42 	Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc.,
the Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on
Form 8-K filed on June 23, 2017.
4.43 	Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc., the
Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on
Form 8-K filed on July 6, 2017.
10.1 	Form of Performance Share Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022— incorporated by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on February 16, 2022.
10.2 	Form of Stock Option Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022— incorporated by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on February 16, 2022.
43

-- 46 of 74 --

10.3 	Form of Restricted Stock Unit Agreement for grants under the 2014 Equity Plan, as adopted February 16, 2022— incorporated by reference to Exhibit 10.3 to
the Company’s Current Report on Form 8-K filed on February 16, 2022.
10.4 	The Coca-Cola Company 2014 Equity Plan, as amended and restated as of February 16, 2022.
31.1 	Rule 13a-14(a)/15d-14(a) Certification, executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola
Company.
31.2 	Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, Executive Vice President and Chief Financial Officer of The Coca-Cola Company.
32.1 	Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350),
executed by James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, and by John Murphy, Executive
Vice President and Chief Financial Officer of The Coca-Cola Company.
101 	The following financial information from The Coca-Cola Company’s Quarterly Report on Form 10-Q for the quarter ended April 1, 2022, formatted in iXBRL
(Inline Extensible Business Reporting Language): (i) Consolidated Statements of Income for the three months ended April 1, 2022 and April 2, 2021; (ii)
Consolidated Statements of Comprehensive Income for the three months ended April 1, 2022 and April 2, 2021; (iii) Consolidated Balance Sheets as of April 1,
2022 and December 31, 2021; (iv) Consolidated Statements of Cash Flows for the three months ended April 1, 2022 and April 2, 2021; and (v) Notes to
Consolidated Financial Statements.
104 	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document).
44

-- 47 of 74 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ KATHY LOVELESS
Date: 	April 28, 2022 	Kathy Loveless
Vice President and Controller
(On behalf of the Registrant)
/s/ MARK RANDAZZA
Date: 	April 28, 2022 	Mark Randazza
Vice President, Assistant Controller and Chief Accounting Officer
(Principal Accounting Officer)
45

-- 48 of 74 --

Exhibit 10.4
THE COCA-COLA COMPANY 2014 EQUITY PLAN
As Amended and Restated as of February 16, 2022
ARTICLE 1 PURPOSE
1.1. GENERAL. The purpose of The Coca-Cola Company 2014 Equity Plan is to promote the success and enhance the value of The Coca-Cola
Company by linking the personal interests of employees, officers and directors of the Company to those of Company shareowners and by providing
such persons with an incentive for outstanding performance. The Plan is further intended to provide flexibility to the Company in its ability to motivate,
attract, and retain the services of employees, officers and directors upon whose judgment, interest, and special effort the successful conduct of the
Company’s operation is largely dependent.
ARTICLE 2 DEFINITIONS
2.1. DEFINITIONS. As used in this plan, the following words and phrases shall have the following meanings:
“Affiliate” means any entity:
i) 	in which the Company owns, directly or indirectly, 20% or more of the voting stock or capital at the relevant time,
ii) 	that has an ongoing contractual relationship with the Company or a Subsidiary that provides such entity the rights to
(a) manufacture, prepare, package, and/or distribute, and
(b) sell to customers or consumers
beverages/brands for which the trademark is owned by the Company or a Subsidiary, or
iii) 	that is approved by the Committee as an Affiliate based on its relationship with the Company or its Subsidiaries.
“Award” means an award of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards, Dividend
Equivalents, Other Stock-Based Awards, or any other right or interest relating to Stock or cash, made to an Eligible Participant under the Plan.
“Award Agreement ” means a written document, in such form as the Committee prescribes from time to time, setting forth the terms and
conditions of an Award. The Committee may provide for the use of electronic, internet or other non-paper Award Agreements, and the use of
electronic, internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.
“Award Date” of an Award means the first date on which all necessary corporate action has been taken to approve the grant of the Award as
provided in the Plan, or such later date as is determined and specified as part of that authorization process.
“Board” means the Board of Directors of the Company.

-- 49 of 74 --

“Change in Control” means a change in control of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of
Regulation 14A under the 1934 Act, provided that such a change in control shall be deemed to have occurred at such time as (i) any person, is
or becomes the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act) directly or indirectly, of securities representing 20% or more
of the combined voting power for election of directors of the then outstanding securities of the Company or any successor of the Company; (ii)
during any period of two consecutive years or less, individuals who at the beginning of such period constituted the Board cease, for any reason,
to constitute at least a majority of the Board, unless the election or nomination for election of each new director was approved by a vote of at
least two-thirds of the directors then still in office who were directors at the beginning of the period; (iii) the shareowners of the Company
approve any merger or consolidation as a result of which the Stock shall be changed, converted or exchanged (other than a merger with a
wholly owned subsidiary of the Company) or any liquidation of the Company or any sale or other disposition of 50% or more of the assets or
earning power of the Company, and such merger, consolidation, liquidation or sale is completed; or (iv) the shareowners of the Company
approve any merger or consolidation to which the Company is a party as a result of which the persons who were shareowners of the Company
immediately prior to the effective date of the merger or consolidation shall have beneficial ownership of less than 50% of the combined voting
power for election of directors of the surviving corporation following the effective date of such merger or consolidation, and such merger or
consolidation is completed; provided, however, that no Change in Control shall be deemed to have occurred if, prior to such times as a Change
in Control would otherwise be deemed to have occurred, the Board determines otherwise. Additionally, no Change in Control will be deemed
to have occurred under clause (i) if, subsequent to such time as a Change in Control would otherwise be deemed to have occurred, a majority of
the Board in office prior to the acquisition of the securities by such person determines otherwise.
“Code” means the Internal Revenue Code of 1986, as amended from time to time. For purposes of this Plan, references to sections of the Code
shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision.
“Committee” means the Talent and Compensation Committee of the Board.
“Company” means The Coca-Cola Company, a Delaware corporation, and its successors.
“Continuous Service” means the absence of any interruption or termination of service as an employee, officer or director of the Company or
any Affiliate, as applicable; Continuous Service will not be interrupted under any of the following cases:
(i) 	a Participant transfers employment, without interruption, between the Company and an Affiliate or between Affiliates,
(ii) 	in the case of a spin-off, sale or disposition of the Participant’s employer from the Company or any Subsidiary, but only if the
Committee determines before the transaction closes that it will not result in an interruption of service; or
(iii) 	the Participant is granted an unpaid leave of absence authorized in writing by the Company prior to its commencement that does not
exceed twelve months. The Committee has final and conclusive authority to determine whether any other leave of absence constitutes a
termination of Continuous Service. Any other leave of absence granted to a Participant must constitute a “bona fide leave of absence”
under Treas. Reg. Section 1.409A-1(h) if the Participant’s Award is subject to Code Section 409A.
“Covered Employee” means a covered employee as defined in Code Section 162(m)(3).

-- 50 of 74 --

“Disability” means a condition for which the Participant becomes eligible for a disability benefit under the long term disability insurance policy
issued to the Company providing basic long term disability insurance benefits pursuant to The Coca-Cola Company Health and Welfare
Benefits Plan, or under any other long term disability plan which hereafter may be maintained by the Company, whether or not the Participant
is covered by such plan. In the event of a dispute, the determination of whether a Participant has incurred a Disability will be made by the
Committee and may be supported by the advice of a physician competent in the area to which such Disability relates.
“Dividend Equivalent” means a right granted to a Participant under Article 12.
“Effective Date” has the meaning assigned such term in Section 3.1.
“Eligible Participant” means an employee, officer or director of the Company or any Subsidiary.
“Exchange” means the New York Stock Exchange, or if the Stock is no longer listed on the New York Stock Exchange, any national securities
exchange on which the Stock may from time to time be listed.
“Fair Market Value,” on any date, means (i) the average of the high and low market prices at which a share of Stock shall have been sold on the
date of the Award, or on the next preceding trading day if such date was not a trading date, as reported on the New York Stock Exchange
Composite Transactions listing, or (ii) if the Stock is not listed on the New York Stock Exchange, Fair Market Value will be determined by
such other method as the Committee determines in good faith to be reasonable and in compliance with Code Section 409A. Notwithstanding
the foregoing, for purposes of determining the tax withholding obligation of the Company or any Affiliate with respect to an Award, or for such
other purposes as the Committee deems appropriate, the Committee may determine the Fair Market Value of the Stock by using any method it
determines in good faith to be reasonable and consistent with applicable provisions of the Code.
“Full-Value Award ” means an Award other than in the form of an Option or SAR, and which is settled by the issuance of Stock (or at the
discretion of the Committee, settled in cash valued by reference to Stock value).
“Independent Directors” means those members of the Board who qualify at any given time as (a) an “independent” director under the
applicable rules of the Exchange, (b) a “non- employee” director under Rule 16b-3 of the 1934 Act, and (c) an “outside” director under Code
Section 162(m).
“Non-Employee Director” means a director of the Company who is not a common law employee of the Company or a Subsidiary.
“Option” means a right granted to a Participant under Article 7 of the Plan to purchase Stock at a specified price during specified time periods.
“Other Stock-Based Award ” means a right granted to a Participant under Article 13, that relates to or is valued by reference to Stock or other
Awards relating to Stock.
“Participant” means an individual to whom an Award has been made under the Plan.

-- 51 of 74 --

“Performance Award” means any award made under the Plan pursuant to Article 10.
“Plan” means The Coca-Cola Company 2014 Equity Plan, as amended from time to time.
“Prior Plans” means The Coca-Cola Company 1999 Stock Option Plan, The Coca-Cola Company 2002 Stock Option Plan, The Coca-Cola
Company 2008 Stock Option Plan, The Coca-Cola Company 1983 Stock Option Plan, The Coca-Cola Company 1989 Restricted Stock Plan,
Coca-Cola Enterprises Inc. 2001 Stock Option Plan, Coca-Cola Enterprises Inc. 2004 Stock Award Plan and Coca-Cola Enterprises Inc. 2007
Incentive Award Plan.
“Qualified Performance-Based Award ” means an Award that is either (i) intended to qualify for the Section 162(m) Exemption and is made
subject to performance goals based on Qualified Business Criteria as set forth in Section 11.2, or (ii) an Option or SAR having an exercise price
equal to or greater than the Fair Market Value of the underlying Stock as of the Award Date.
“Qualified Business Criteria” means one or more of the business criteria listed in Section 11.2 upon which performance goals for certain
Qualified Performance-Based Awards may be established by the Committee.
“Restricted Stock” means Stock granted to a Participant under Article 9 that is subject to certain restrictions and to risk of forfeiture.
“Restricted Stock Unit” means the right granted to a Participant under Article 9 to receive shares of Stock (or the equivalent value in cash
subject to 14.2) in the future, which right is subject to certain restrictions and to risk of forfeiture.
“Section 162(m) Exemption” means the exemption from the limitation on deductibility imposed by Code Section 162(m) that is set forth in
Code Section 162(m)(4)(C) or any successor provision thereto.
“Shares” means shares of the Stock. If there has been an adjustment or substitution with respect to the Shares (whether or not pursuant to
Article 15), the term “Shares” shall also include any shares of stock or other securities that are substituted for Shares or into which Shares are
adjusted.
“Stock” means the $0.25 par value common stock of the Company and such other securities of the Company as may be substituted for Stock
pursuant to Article 15.
“Stock Appreciation Right” or “SAR” means a right granted to a Participant under Article 8 to receive a payment equal to the difference
between the Fair Market Value of a Share as of the date of exercise of the SAR over the base price of the SAR, all as determined pursuant to
Article 8.
“Subsidiary” means any corporation, limited liability company, partnership or other entity, of which 50% or more of the outstanding voting
stock or voting power is beneficially owned directly or indirectly by the Company.
“Substitute Award” means an Award under Section 14.9 of the Plan.
“1933 Act” means the Securities Act of 1933, as amended from time to time.
“1934 Act” means the Securities Exchange Act of 1934, as amended from time to time.

-- 52 of 74 --

ARTICLE 3 EFFECTIVE TERM OF PLAN
3.1. EFFECTIVE DATE. Subject to the approval of the Plan by the Company’s shareowners within 12 months after the Plan’s adoption by
the Board, the Plan will become effective on February 20, 2014, the date the Plan was adopted by the Board (the “Effective Date”).
3.2. TERMINATION OF PLAN . Unless earlier terminated as provided herein, the Plan shall continue in effect until the date of the
Company’s 2024 annual shareowners’ meeting or, if the shareowners approve an amendment to the Plan that increases the number of Shares subject to
the Plan, the tenth anniversary of the date of such approval. The termination of the Plan on such date shall not affect the validity of any Award
outstanding on the date of termination, which shall continue to be governed by the applicable terms and conditions of the Plan.
ARTICLE 4 ADMINISTRATION
4.1. COMMITTEE. The Plan shall be administered by the Committee. It is intended that at least two of the directors appointed to serve on the
Committee shall be Independent Directors and that any such members of the Committee who do not so qualify shall abstain from participating in any
decision to make or administer Awards that are made to Eligible Participants who at the time of consideration for such Award (i) are persons subject to
the short-swing profit rules of Section 16 of the 1934 Act, or (ii) are Covered Employees or are reasonably anticipated to become Covered Employees
during the term of the Award. However, the mere fact that a Committee member fails to qualify as an Independent Director or fails to abstain from such
action shall not invalidate any Award made by the Committee if the Award is otherwise validly made under the Plan.
4.2. ACTION AND INTERPRETATIONS BY THE COMMITTEE . The Committee may from time to time adopt rules, regulations,
guidelines and procedures for carrying out the provisions and purposes of the Plan and make such other determinations, not inconsistent with the Plan,
as the Committee may deem appropriate. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in
any Award in the manner and to the extent it deems necessary to carry out the intent of the Plan. The Committee’s interpretation of the Plan, any
Awards made under the Plan, any Award Agreement and all decisions and determinations by the Committee with respect to the Plan are final, binding,
and conclusive on all parties. No member of the Committee will be liable for any good faith determination, act or omission in connection with the Plan
or any Award.
4.3. AUTHORITY OF COMMITTEE. Except as provided in Section 4.1 and 4.4 hereof, the Committee has the exclusive power, authority
and discretion to:
(a) 	Make Awards;
(b) 	Designate Participants;
(c) 	Determine the type or types of Awards to be made to each Participant;
(d) 	Determine the number of Awards to be made and the number of Shares or dollar amount to which an Award will relate;
(e) 	Determine the terms and conditions of any Award made under the Plan;

-- 53 of 74 --

(f) 	Prescribe the form of each Award Agreement, which need not be identical for each Participant;
(g) 	Decide all other matters that must be determined in connection with an Award;
(h) 	Establish, adopt or revise any rules, regulations, guidelines or procedures as it may deem necessary or advisable to administer the Plan;
(i) 	Make all other decisions and determinations that may be required under the Plan or as the Committee deems necessary or advisable to
administer the Plan;
(j) 	Amend the Plan or any Award Agreement as provided herein; and
(k) 	Adopt such modifications, procedures, and subplans as may be necessary or desirable to comply with provisions of the laws of the
United States or any non-U.S. jurisdictions in which the Company or any Affiliate may operate, in order to assure the viability of the
benefits of Awards made to Participants located in the United States or such other jurisdictions and to further the objectives of the Plan.
Notwithstanding any of the foregoing, Awards made to Non-Employee Directors hereunder shall (i) be subject to the applicable award limits set forth in
Section 5.4 hereof, and (ii) be made only in accordance with the terms, conditions and parameters of a plan, program or policy for the compensation of
Non-Employee Directors as in effect from time to time that is approved and administered by a committee of the Board consisting solely of Independent
Directors. The Committee may not make other discretionary grants hereunder to Non-Employee Directors.
4.4. 	DELEGATION.
(a) 	Administrative Duties. The Committee may delegate to one or more of its members or to one or more officers of the Company or to
one or more agents or advisors such administrative duties or powers as it may deem advisable, and the Committee or any individuals to
whom it has delegated duties or powers as aforesaid may employ one or more individuals to render advice with respect to any
responsibility the Committee or such individuals may have under this Plan.
(b) 	Special Committee. The Committee may delegate to a special committee, consisting of one or more Independent Directors, the
authority, within specified parameters as to the number and terms of Awards, to make Awards under this Plan, including to (i) designate
officers and/or employees of the Company or any of its Subsidiaries to be recipients of Awards under the Plan, and (ii) to determine the
number of such Awards to be received by any such Participants; provided, however, that such delegation of duties and responsibilities
may not be made with respect to the Awards made to Eligible Participants (a) who are subject to Section 16(a) of the 1934 Act at the
Award Date, or (b) who as of the Award Date are Covered Employees or are reasonably anticipated to be become Covered Employees
during the term of the Award. The acts of such delegates shall be treated hereunder as acts of the Committee and such delegates shall
report regularly to the Committee regarding the delegated duties and responsibilities and any Awards so granted.

-- 54 of 74 --

ARTICLE 5
SHARES SUBJECT TO THE PLAN
5.1. NUMBER OF SHARES. Subject to adjustment as provided in Sections 5.2 and Section 15.1, the aggregate number of Shares reserved
and available for issuance pursuant to Awards granted under the Plan shall be 500,000,000, which includes 66,948,651 Shares that were available for
future grant under the Prior Plans as of the Effective Date. After the Effective Date, no further awards shall be made under the Prior Plans and the Prior
Plans shall remain in effect only so long as awards made thereunder shall remain outstanding; provided, however, that Awards under Prior Plans may
be made after the Effective Date subject to the following limitations: (1) 500,000 Shares under The Coca-Cola Company 1999 Stock Option Plan shall
be reserved for future awards made to Eligible Participants located in the United Kingdom, (2) 1,000,000 Shares under The Coca-Cola Company 2008
Stock Option Plan and 150,000 Shares under The Coca-Cola Company 1989 Restricted Stock Award Plan shall be reserved for awards made to
Eligible Participants located in China who are subject to the State Administration of Foreign Exchange rules, and (3) 1,700,000 Shares under The
Coca-Cola Company 2008 Stock Option Plan and 250,000 Shares under The Coca-Cola Company 1989 Restricted Stock Award Plan shall be reserved
for awards made in 2014 outside of the normal equity award cycle to Eligible Participants.
5.2. SHARE COUNTING. Shares covered by an Award shall be subtracted from the Plan share reserve as of the Award Date as provided in
subsection (a) below, but shall be added back to the Plan share reserve or otherwise treated in accordance with subsections (b) through (h) of this
Section 5.2.
(a) 	Awards of Options and Stock Appreciation Rights shall count against the number of Shares remaining available for issuance pursuant
to Awards granted under the Plan as one Share for each Share covered by such Awards, and Full Value Awards shall count against the
number of Shares remaining available for issuance pursuant to Awards granted under the Plan as 5.0 Shares for each Share covered by
such Awards.
(b) 	The full number of Shares subject to an Option shall count against the number of Shares remaining available for issuance pursuant to
Awards made under the Plan, even if the exercise price of an Option is satisfied through net-settlement or by delivering Shares to the
Company (by either actual delivery or attestation).
(c) 	Upon exercise of Stock Appreciation Rights that are settled in Shares, the full number of Stock Appreciation Rights (rather than the net
number of Shares actually delivered upon exercise) shall count against the number of Shares remaining available for issuance pursuant
to Awards granted under the Plan.
(d) 	Shares withheld from an Award to satisfy tax withholding requirements shall count against the number of Shares remaining available
for issuance pursuant to Awards granted under the Plan, and Shares delivered by a Participant to satisfy tax withholding requirements
shall not be added to the Plan share reserve.
(e) 	Shares repurchased on the open market with the proceeds from the exercise of an Option shall not again be made available for issuance
under the Plan.
(f) 	To the extent that all or a portion of an Award is canceled, terminates, expires, is forfeited or lapses for any reason, including by reason
of failure to meet time-based vesting requirements or to achieve performance goals, any unissued or

-- 55 of 74 --

forfeited Shares subject to the Award will be added back to the Plan share reserve and again be available for issuance pursuant to
Awards made under the Plan.
(g) 	Shares subject to Awards settled in cash will be added back to the Plan share reserve and again be available for issuance under the Plan.
(h) 	Substitute Awards made pursuant to Section 14.9 of the Plan shall not count against the Shares otherwise available for issuance under
the Plan under Section 5.1.
(i) 	Subject to applicable Exchange requirements, shares available under a shareowner-approved plan of a company acquired by the
Company (as appropriately adjusted to Shares to reflect the transaction) may be issued under the Plan pursuant to Awards made to
individuals who were not employees of the Company or its Subsidiaries immediately before such transaction and will not count against
the maximum share limitation specified in Section 5.1.
5.3. STOCK DISTRIBUTED. Any Stock distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Stock,
treasury Stock or Stock purchased on the open market and may be subject to restrictions deemed appropriate by the Committee.
5.4. LIMITATION ON AWARDS. Notwithstanding any provision in the Plan to the contrary (but subject to adjustment as provided in Article
15):
(a) 	Options. The maximum number of Options granted under the Plan in any calendar year to any one Participant shall be for 3,000,000
Shares.
(b) 	SARs. The maximum number of Stock Appreciation Rights granted under the Plan in any calendar year to any one Participant shall be
3,000,000 with respect to Shares.
(c) 	Performance Awards . With respect to any one calendar year (i) the maximum amount that may be paid to any one Participant for
Performance Awards payable in cash or property other than Shares shall be $20,000,000, and (ii) the maximum number of Shares that
may be paid to any one Participant for Performance Awards payable in Stock shall be 1,000,000 Shares. For purposes of applying these
limits in the case of multi-year performance periods, the amount of cash or property or number of Shares deemed paid with respect to
any one calendar year is the total amount payable or Shares earned for the performance period divided by the number of calendar years
in the performance period.
(d) 	Awards to Non-Employee Directors . The maximum aggregate number of Shares associated with any Award made under the Plan in
any calendar year to any one Non-Employee Director shall be 25,000 Shares.
ARTICLE 6 ELIGIBILITY
6.1. GENERAL. Awards may be granted only to Eligible Participants who are providing services to the Company or a Subsidiary.

-- 56 of 74 --

ARTICLE 7 STOCK OPTIONS
7.1. GENERAL. The Committee is authorized to grant Options to Eligible Participants on the following terms and conditions:
(a) 	Exercise Price. The exercise price per Share under an Option shall be determined by the Committee, provided that the exercise price
for any Option (other than an Option issued as a substitute Award pursuant to Section 14.9) shall not be less than the Fair Market Value
as of the Award Date.
(b) 	Prohibition on Repricing. Except as otherwise provided in Article 15, without the prior approval of the shareowners of the Company:
(i) the exercise price of an Option may not be reduced, directly or indirectly, (ii) an Option may not be cancelled in exchange for cash,
other Awards, or Options or SARs with an exercise or base price that is less than the exercise price of the original Option, or otherwise,
and (iii) the Company may not repurchase an Option for value (in cash, substitutions, cash buyouts, or otherwise) from a Participant if
the current Fair Market Value of the Shares underlying the Option is lower than the exercise price per share of the Option.
(c) 	Time and Conditions of Exercise . The Committee shall determine the time or times at which an Option may be exercised in whole or in
part, subject to Section 7.1(e); provided, however, that, except in the event of a Change in Control, Disability or death of the
Participant, no award shall provide that an Option shall be exercisable in whole or in part for a period of twelve months from Award
Date. The Committee shall also determine the performance or other conditions, if any, that must be satisfied before all or part of an
Option may be exercised or vested.
(d) 	Payment. The Committee shall determine the methods by which the exercise price of an Option may be paid, the form of payment, and
the methods by which Shares shall be delivered or deemed to be delivered to Participants. As determined by the Committee at or after
the Award Date, payment of the exercise price of an Option may be made, in whole or in part, in the form of (i) cash or cash
equivalents, (ii) delivery (by either actual delivery or attestation) of previously-acquired Shares based on the Fair Market Value of the
Shares on the date the Option is exercised,
(iii) withholding of Shares from the Option based on the Fair Market Value of the Shares on the date the Option is exercised, (iv)
broker-assisted market sales, or (v) any other “cashless exercise” arrangement.
(e) 	Exercise Term. No Option granted under the Plan shall be exercisable for more than ten years from the Award Date.
(f) 	No Deferral Feature. No Option shall provide for any feature for the deferral of compensation other than the deferral of recognition of
income until the exercise or disposition of the Option.
(g) 	No Dividend Equivalents. No Option shall provide for Dividend Equivalents.

-- 57 of 74 --

ARTICLE 8
STOCK APPRECIATION RIGHTS
8.1. STOCK APPRECIATION RIGHTS. The Committee is authorized to grant Stock Appreciation Rights to Eligible Participants on the
following terms and conditions:
(a) 	Right to Payment. Upon the exercise of a SAR, the Participant has the right to receive, for each Share with respect to which the SAR is
being exercised, the excess, if any, of:
(1) 	The Fair Market Value of one Share on the date of exercise; over
(2) 	The base price of the SAR as determined by the Committee and set forth in the Award Agreement, which shall not be less than
the Fair Market Value of one Share on the Award Date.
(b) 	Prohibition on Repricing. Except as otherwise provided in Article 15, without the prior approval of the shareowners of the Company:
(i) the base price of a SAR may not be reduced, directly or indirectly, (ii) a SAR may not be cancelled in exchange for cash, other
Awards, or Options or SARs with an exercise or base price that is less than the base price of the original SAR, and (iii) the Company
may not repurchase a SAR for value (in cash, substitutions, cash buyouts, or otherwise) from a Participant if the current Fair Market
Value of the Shares underlying the SAR is lower than the base price per share of the SAR.
(c) 	Time and Conditions of Exercise . The Committee shall determine the time or times at which a SAR may be exercised in whole or in
part. No SAR shall be exercisable for more than ten years from the Award Date.
(d) 	No Deferral Feature. No SAR shall provide for any feature for the deferral of compensation other than the deferral of recognition of
income until the exercise or disposition of the SAR.
(e) 	No Dividend Equivalents. No SAR shall provide for Dividend Equivalents.
ARTICLE 9
RESTRICTED STOCK AND STOCK UNITS
9.1. RESTRICTED STOCK AND STOCK UNITS. The Committee is authorized to make Awards of Restricted Stock and Restricted Stock
Units to Eligible Participants in such amounts and subject to such terms and conditions as may be selected by the Committee.
9.2. ISSUANCE AND RESTRICTIONS. Restricted Stock and Restricted Stock Units shall be subject to such restrictions on transferability
and other restrictions as the Committee may impose. These restrictions may lapse separately or in combination at such times, under such
circumstances, in such installments, upon the satisfaction of performance goals or otherwise, as the Committee determines at the time of the grant of
the Award or thereafter. Except as otherwise provided in an Award Agreement or any special Plan document governing an Award, a Participant shall
have none of the rights of a shareowner with respect to Restricted Stock Units until Shares of Stock are released in settlement of such Awards.
9.3 DIVIDENDS ON RESTRICTED STOCK UNITS . In the case of Restricted Stock Units, the Participant shall not be entitled to receive
dividends or Dividend Equivalents unless the

-- 58 of 74 --

Award Agreement specifically provides for such dividends or Dividend Equivalents, subject to Section 12.1.
9.4. FORFEITURE. Subject to the terms of the Award Agreement and except as otherwise determined by the Committee at the time of the
grant of the Award or thereafter, upon termination of Continuous Service during the applicable restriction period or upon failure to satisfy a
performance goal during the applicable restriction period, Restricted Stock or Restricted Stock Units that are at that time subject to restrictions shall be
forfeited.
9.5. DELIVERY OF RESTRICTED STOCK . Shares of Restricted Stock shall be delivered to the Participant at the Award Date either by
book-entry registration or by delivering to the Participant, or a custodian or escrow agent (including, without limitation, the Company or one or more of
its employees) designated by the Committee, a stock certificate or certificates registered in the name of the Participant. If physical certificates
representing shares of Restricted Stock are registered in the name of the Participant, such certificates must bear an appropriate legend referring to the
terms, conditions, and restrictions applicable to such Restricted Stock.
ARTICLE 10 PERFORMANCE AWARDS
10.1. PERFORMANCE AWARDS . The Committee is authorized to make any Award under this Plan, including cash-based Awards, with
performance-based vesting criteria, on such terms and conditions as may be selected by the Committee. Any such Awards with performance- based
vesting criteria are referred to herein as Performance Awards. The Committee shall have the complete discretion to determine the number of
Performance Awards made to each Eligible Participant, subject to Section 5.4, and to designate the provisions of such Performance Awards as provided
in Section 4.3. All Performance Awards shall be evidenced by an Award Agreement or a written program established by the Committee, pursuant to
which Performance Awards are awarded under the Plan under uniform terms, conditions and restrictions set forth in such written program.
10.2. PERFORMANCE GOALS. The Committee may establish performance goals for Performance Awards which may be based on any
criteria selected by the Committee. Such performance goals may be described in terms of Company-wide objectives or in terms of objectives that relate
to the performance of the Participant, a Subsidiary or a division, region, department or function within the Company or a Subsidiary. If the Committee
determines that a change in the business, operations, corporate structure or capital structure of the Company or the manner in which the Company or a
Subsidiary conducts its business, or other events or circumstances render performance goals to be unsuitable, the Committee may modify such
performance goals in whole or in part, as the Committee deems appropriate. If a Participant is promoted, demoted or transferred to a different business
unit or function during a performance period, the Committee may determine that the performance goals or performance period are no longer
appropriate and may (i) adjust, change or eliminate the performance goals or the applicable performance period as it deems appropriate to make such
goals and period comparable to the initial goals and period, or (ii) make a cash payment to the Participant in an amount determined by the Committee.
The foregoing two sentences shall not apply with respect to a Performance Award that is intended to be a Qualified Performance-Based Award.
ARTICLE 11
QUALIFIED PERFORMANCE-BASED AWARDS
11.1. OPTIONS AND STOCK APPRECIATION RIGHTS . All Options and Stock Appreciation Rights granted to any Covered Employee are
intended to qualify for the Section

-- 59 of 74 --

162(m) Exemption as Qualified Performance-Based Awards even though they are not designated as Performance Awards.
11.2. PERFORMANCE AWARDS . For any Performance Awards that are intended to be Qualified Performance-Based Awards, the
Committee shall establish performance goals for such Award within the time period prescribed by Code Section 162(m) based on one or more of the
following Qualified Business Criteria, which may be expressed in terms of Company-wide objectives or in terms of objectives that relate to the
performance of a Subsidiary or a division, region, department or function within the Company or a Subsidiary:
• 	increase in shareowner value (e.g., total shareowner return);
• 	earnings per share;
• 	stock price;
• 	net income;
• 	return on assets;
• 	return on shareowners' equity;
• 	cash flow;
• 	operating profit or operating margins;
• 	revenue growth of the Company;
• 	operating expenses;
• 	quality as determined by the Company's Quality Index;
• 	economic profit;
• 	return on capital;
• 	return on invested capital;
• 	earnings before interest, taxes, depreciation and amortization;
• 	goals relating to acquisitions or divestitures;
• 	unit case volume;
• 	operating income;
• 	brand contribution;
• 	value share of Non Alcoholic Ready-To-Drink segment;
• 	volume share of Non Alcoholic Ready-To-Drink segment;
• 	net revenue;
• 	gross profit;
• 	profit before tax;
• 	number of transactions;
• 	productivity; and
• 	service level.
Performance goals with respect to the foregoing Qualified Business Criteria may be specified in absolute terms, in percentages, or in terms of growth
from period to period or growth rates over time, as well as measured relative to the performance of a group of comparator companies, or a published or
special index, or a stock market index, that the Committee deems appropriate, and may be calculated for a single year or calculated on a compound
basis over multiple years. Any member of a comparator group or an index that ceases to exist during a measurement period shall be disregarded for the
entire measurement period. Performance Goals need not be based upon an increase or positive result under a business criterion and could include, for
example, the maintenance of the status quo or the limitation of economic losses (measured, in each case, by reference to a specific business criterion).
Performance measures may but need not be determinable in conformance with generally accepted accounting principles.
11.3. ACHIEVEMENT OF PERFORMANCE GOALS. Each Qualified Performance- Based Award (other than a market-priced Option or
SAR) shall be earned, vested and payable (as applicable) only upon the achievement of performance goals established by the Committee based

-- 60 of 74 --

upon one or more of the Qualified Business Criteria, together with the satisfaction of any other conditions, such as continued employment, as the
Committee may determine to be appropriate; provided, however, that the Committee may provide, either in connection with the grant thereof or by
amendment thereafter, that achievement of such performance goals will be waived, in whole or in part, upon (i) the termination of employment of a
Participant by reason of death or Disability, or
(ii) the occurrence of a Change in Control. Performance periods established by the Committee for any such Qualified Performance-Based Award must
be at least twelve months and may be any longer period. In addition, the Committee has the right, in connection with the grant of a Qualified
Performance-Based Award, to exercise negative discretion to determine that the portion of such Award actually earned, vested and/or payable (as
applicable) shall be less than the portion that would be earned, vested and/or payable based solely upon application of the applicable performance
goals.
11.4. INCLUSIONS AND EXCLUSIONS FROM PERFORMANCE CRITERIA. The Committee may provide in any Qualified Performance-
Based Award, at the time the performance goals are established, that any evaluation of performance shall exclude or otherwise objectively adjust for
any specified circumstance or event that occurs during a performance period, including by way of example but without limitation the following: (a)
asset write-downs or impairment charges; (b) litigation or claim judgments or settlements; (c) the effect of changes in tax laws, accounting principles or
other laws or provisions affecting reported results; (d) accruals for reorganization and restructuring programs; (e) extraordinary nonrecurring items as
described in then-current accounting principles; (f) extraordinary nonrecurring items as described in management’s discussion and analysis of financial
condition and results of operations appearing in the Company’s annual report to shareowners for the applicable year; (g) acquisitions or divestitures;
and (h) foreign exchange gains and losses. To the extent such inclusions or exclusions affect Awards to Covered Employees, they shall be prescribed in
a form that meets the requirements of Code Section 162(m) for deductibility.
11.5. CERTIFICATION OF PERFORMANCE GOALS . Any payment of a Qualified Performance-Based Award granted with performance
goals pursuant to Section 11.3 above shall be conditioned on the written certification of the Committee in each case that the performance goals and any
other material conditions were satisfied. Except as specifically provided in Section 11.3, no Qualified Performance-Based Award held by a Covered
Employee or by an employee who in the reasonable judgment of the Committee may be a Covered Employee on the date of payment, may be
amended, nor may the Committee exercise any discretionary authority it may otherwise have under the Plan with respect to a Qualified Performance-
Based Award under the Plan, in any manner to waive the achievement of the applicable performance goal based on Qualified Business Criteria or to
increase the amount payable pursuant thereto or the value thereof, or otherwise in manner that would cause the Qualified Performance-Based Award to
cease to qualify for the Section 162(m) Exemption.
ARTICLE 12 DIVIDEND EQUIVALENTS
12.1. GRANT OF DIVIDEND EQUIVALENTS. The Committee is authorized to pay Dividend Equivalents with respect to Full-Value Awards
made hereunder, subject to such terms and conditions as may be selected by the Committee. Dividend Equivalents shall entitle the Participant to
receive payments equal to ordinary cash dividends or distributions with respect to all or a portion of the number of Shares subject to a Full-Value
Award, as determined by the Committee. The Committee may provide that Dividend Equivalents (i) will be deemed to have been reinvested in
additional Shares or otherwise reinvested, or (ii) except in the case of Performance Awards, will be paid or distributed to the Participant as accrued (in
which case, such Dividend Equivalents must be paid or distributed no later than the 15th day of the 3rd month following the later of (A) the end of the
calendar year in which the corresponding dividends were

-- 61 of 74 --

paid to shareowners, or (B) the end of the first calendar year in which the Participant’s right to such Dividends Equivalents is no longer subject to a
substantial risk of forfeiture).
ARTICLE 13
STOCK OR OTHER STOCK-BASED AWARDS
13.1. STOCK OR OTHER STOCK-BASED AWARDS . The Committee is authorized, subject to limitations under applicable law, to make
such other Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to Shares, as deemed by the
Committee to be consistent with the purposes of the Plan, including without limitation Shares awarded purely as a “bonus” and not subject to any
restrictions or conditions, convertible or exchangeable debt securities, other rights convertible or exchangeable into Shares, and Awards valued by
reference to book value of Shares or the value of securities of or the performance of specified Parents or Subsidiaries. The Committee shall determine
the terms and conditions of such Awards.
ARTICLE 14
PROVISIONS APPLICABLE TO AWARDS
14.1. AWARD AGREEMENTS . Each Award shall be evidenced by an Award Agreement. Each Award Agreement shall include such
provisions, not inconsistent with the Plan, as may be specified by the Committee.
14.2. FORM OF PAYMENT FOR AWARDS . At the discretion of the Committee, payment of Awards may be made in cash, Stock, a
combination of cash and Stock, or any other form of property as the Committee shall determine. In addition, payment of Awards may include such
terms, conditions, restrictions and/or limitations, if any, as the Committee deems appropriate, including, in the case of Awards paid in the form of
Stock, restrictions on transfer and forfeiture provisions.
14.3. LIMITS ON TRANSFER. No right or interest of a Participant in any unexercised or restricted Award may be pledged, encumbered, or
hypothecated to or in favor of any party other than the Company or a Subsidiary, or shall be subject to any lien, obligation, or liability of such
Participant to any other party other than the Company or a Subsidiary. No unexercised or restricted Award shall be assignable or transferable by a
Participant other than by will or the laws of descent and distribution.
14.4. STOCK TRADING RESTRICTIONS. All Stock issuable under the Plan is subject to any stop-transfer orders and other restrictions as the
Committee deems necessary or advisable to comply with federal or state securities laws, rules and regulations and the rules of any national securities
exchange or automated quotation system on which the Stock is listed, quoted, or traded. The Committee may place legends on any Stock Agreement or
issue instructions to the transfer agent to reference restrictions applicable to the Stock.
14.5. TREATMENT UPON TERMINATION OF SERVICE . The applicable Award Agreement or other special Plan document governing an
Award shall specify the treatment of such Award upon the termination of a Participant’s Continuous Service.
14.6. EFFECT OF A CHANGE IN CONTROL . The provisions of this Section 14.6 shall apply in the case of a Change in Control, unless
otherwise provided in the Award Agreement or any special Plan document or separate agreement with a Participant governing an Award.
(a) 	Awards Assumed or Substituted by Surviving Entity . With respect to Awards assumed by the Surviving Entity or otherwise equitably
converted or substituted

-- 62 of 74 --

in connection with a Change in Control: if within one year after the effective date of the Change in Control, a Participant’s employment
is involuntarily terminated other than for cause, then (i) all of that Participant’s outstanding Options or SARs shall become fully
exercisable, (ii) all time-based vesting restrictions on his or her outstanding Awards shall lapse, and (iii) the payout level under all of
that Participant’s performance-based Awards that were outstanding immediately before the effective time of the Change in Control
shall be determined and deemed to have been earned as of the date of termination based upon (A) an assumed achievement of all
relevant performance goals at the “target” level if the date of termination occurs during the first half of the applicable performance
period, or (B) the actual level of achievement of all relevant performance goals against target (measured as of the end of the calendar
quarter immediately preceding the date of termination), if the date of termination occurs during the second half of the applicable
performance period, and, in either such case, there shall be a pro rata payout to such Participant within 60 days following the date of
termination of employment (unless a later date is required under Section 17.3), based upon the length of time (in days) within the
performance period that has elapsed prior to the date of termination of employment. Any Options or SARs shall thereafter continue or
lapse in accordance with the other provisions of the Plan and the Award Agreement.
(b) 	Awards not Assumed or Substituted by Surviving Entity . Upon the occurrence of a Change in Control, and except with respect to any
Awards assumed by the Surviving Entity or otherwise equitably converted or substituted in connection with the Change in Control in a
manner approved by the Committee or the Board: outstanding Options or SARs shall become fully exercisable, (ii) time-based vesting
restrictions on outstanding Awards shall lapse, and (iii) the payout level attainable under outstanding performance-based Awards shall
be deemed to have been fully earned as of the effective date of the Change in Control based upon (A) an assumed achievement of all
relevant performance goals at the “target” level ifthe Change in Control occurs during the first half of the applicable performance
period, or (B) the actual level of achievement of all relevant performance goals against target measured as of the date of the Change in
Control, if the Change in Control occurs during the second half of the applicable performance period, and, in either such case, there
shall be a pro rata payout to Participants within sixty (60) days following the Change in Control (unless a later date is required by
Section 17.3 hereof), based upon the length of time (in days) within the performance period that has elapsed prior to the Change in
Control. Any Options or SARs shall thereafter continue or lapse in accordance with the other provisions of the Plan and the Award
Agreement.
14.7. ACCELERATION FOR OTHER REASONS . Regardless of whether an event has occurred as described in Section 14.5 or 14.6 above,
and subject to Article 11 as to Qualified Performance-Based Awards, the Committee may in its sole discretion at any time determine that, upon the
termination of service of a Participant for any reason, or the occurrence of a Change in Control, all or a portion of such Participant’s Options or SARs
shall become fully or partially exercisable, that all or a part of the restrictions on all or a portion of the Participant’s outstanding Awards shall lapse,
and/or that any performance-based criteria with respect to any Awards held by that Participant shall be deemed to be wholly or partially satisfied, in
each case, as of such date as the Committee may, in its sole discretion, declare. The Committee may discriminate among Participants and among
Awards made to a Participant in exercising its discretion pursuant to this Section 14.7.

-- 63 of 74 --

14.8. FORFEITURE EVENTS. Awards under the Plan shall be subject to any compensation recoupment policy that the Company may adopt
from time to time that is applicable by its terms to the Participant. In addition, the Committee may specify in an Award Agreement that the Participant’s
rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of
certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but shall not
be limited to, (i) termination of employment for cause, (ii) violation of material Company or Affiliate policies, (iii) breach of noncompetition,
confidentiality or other restrictive covenants that may apply to the Participant, (iv) other conduct by the Participant that is detrimental to the business or
reputation of the Company or any Affiliate, or (v) a later determination that the vesting of, or amount realized from, a Performance Award was based
on materially inaccurate financial statements or any other materially inaccurate performance metric criteria, whether or not the Participant caused or
contributed to such material inaccuracy. The Company shall seek to recover any Award made as required by the provisions of the Dodd-Frank Wall
Street Reform and Consumer Protection Act or any other “clawback” provision required by law or the listing standards of the Exchange.
14.9. SUBSTITUTE AWARDS . The Committee may grant Awards under the Plan in substitution for stock and stock-based awards held by
employees of another entity who become employees of the Company or a Subsidiary as a result of a merger or consolidation of the former employing
entity with the Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the former employing corporation.
The Committee may direct that the substitute awards be made on such terms and conditions as the Committee considers appropriate in the
circumstances.
ARTICLE 15
CHANGES IN CAPITAL STRUCTURE
15.1. MANDATORY ADJUSTMENTS. In the event of a nonreciprocal transaction between the Company and its shareowners that causes the
per-share value of the Stock to change (including, without limitation, any stock dividend, stock split, spin-off, rights offering, or large nonrecurring
cash dividend), the Committee shall make such adjustments to the Plan and Awards as it deems necessary, in its sole discretion, to prevent dilution or
enlargement of rights immediately resulting from such transaction. Action by the Committee may include: (i) adjustment of the number and kind of
shares that may be delivered under the Plan; (ii) adjustment of the number and kind of shares subject to outstanding Awards; (iii) adjustment of the
exercise price or base price of outstanding Awards or the measure to be used to determine the amount of the benefit payable on an Award; and (iv) any
other adjustments that the Committee determines to be equitable. Notwithstanding the foregoing, the Committee shall not make any adjustments to
outstanding Options or SARs that would constitute a modification or substitution of the stock right under Treas. Reg. Sections 1.409A-1(b)(5)(v) that
would be treated as the grant of a new stock right or change in the form of payment for purposes of Code Section 409A. Without limiting the foregoing,
in the event of a subdivision of the outstanding Stock (stock-split), a declaration of a dividend payable in Shares, or a combination or consolidation of
the outstanding Stock into a lesser number of Shares, the authorization limits under Section 5.1 and 5.4 shall automatically be adjusted proportionately,
and the Shares then subject to each Award shall automatically, without the necessity for any additional action by the Committee, be adjusted
proportionately without any change in the aggregate purchase price therefor.
15.2 DISCRETIONARY ADJUSTMENTS . Upon the occurrence or in anticipation of any corporate event or transaction involving the
Company (including, without limitation, any merger, reorganization, recapitalization, combination or exchange of shares, or any transaction described
in Section 15.1), the Committee may, in its sole discretion, provide (i) that Awards will

-- 64 of 74 --

be settled in cash rather than Stock, (ii) that Awards will become immediately vested and non- forfeitable and exercisable (in whole or in part) and will
expire after a designated period of time to the extent not then exercised, (iii) that Awards will be assumed by another party to a transaction or otherwise
be equitably converted or substituted in connection with such transaction, (iv) that outstanding Awards may be settled by payment in cash or cash
equivalents equal to the excess of the Fair Market Value of the underlying Stock, as of a specified date associated with the transaction, over the exercise
or base price of the Award, (v) that performance targets and performance periods for Performance Awards will be modified, consistent with Code
Section 162(m) where applicable, or (vi) any combination of the foregoing. The Committee’s determination need not be uniform and may be different
for different Participants whether or not such Participants are similarly situated.
15.3 GENERAL. Any discretionary adjustments made pursuant to this Article 15 shall be subject to the provisions of Section 16.2.
ARTICLE 16
AMENDMENT, MODIFICATION AND TERMINATION
16.1. AMENDMENT, MODIFICATION AND TERMINATION. The Board or the Committee may, at any time and from time to time, amend,
modify or terminate the Plan without shareowner approval; provided, however, that if an amendment to the Plan would, in the reasonable opinion of the
Board or the Committee, either (i) materially increase the number of Shares available under the Plan, (ii) expand the types of awards under the Plan,
(iii) materially expand the class of participants eligible to participate in the Plan, (iv) materially extend the term of the Plan, or (v) otherwise constitute a
material change requiring shareowner approval under applicable laws, policies or regulations or the applicable listing or other requirements of an
Exchange, then such amendment shall be subject to shareowner approval; and provided, further, that the Board or Committee may condition any other
amendment or modification on the approval of shareowners of the Company for any reason, including by reason of such approval being necessary or
deemed advisable (i) to comply with the listing or other requirements of an Exchange, or (ii) to satisfy any other tax, securities or other applicable laws,
policies or regulations.
16.2. AWARDS PREVIOUSLY MADE. At any time and from time to time, the Committee may amend, modify or terminate any outstanding
Award without approval of the Participant; provided, however:
(a) 	Subject to the terms of the applicable Award Agreement, such amendment, modification or termination shall not, without the
Participant’s consent, reduce or diminish the value of such Award determined as if the Award had been exercised, vested, cashed in or
otherwise settled on the date of such amendment or termination (with the per-share value of an Option or SAR for this purpose being
calculated as the excess, if any, of the Fair Market Value as of the date of such amendment or termination over the exercise or base
price of such Award);
(b) 	The original term of an Option or SAR may not be extended without the prior approval of the shareowners of the Company;
(c) 	Except as otherwise provided in Section 15.1, the exercise price of an Option or base price of a SAR may not be reduced, directly or
indirectly, without the prior approval of the shareowners of the Company; and
(d) 	No termination, amendment, or modification of the Plan shall adversely affect any Award previously made under the Plan, without the
written consent of the Participant affected thereby. An outstanding Award shall not be deemed to be

-- 65 of 74 --

“adversely affected” by a Plan amendment if such amendment would not reduce or diminish the value of such Award determined as if
the Award had been exercised, vested, cashed in or otherwise settled on the date of such amendment (with the per-share value of an
Option or SAR for this purpose being calculated as the excess, if any, of the Fair Market Value as of the date of such amendment over
the exercise or base price of such Award).
16.3. COMPLIANCE AMENDMENTS. Notwithstanding anything in the Plan or in any Award Agreement to the contrary, the Board or the
Committee may amend the Plan or an Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of
conforming the Plan or Award Agreement to any present or future law relating to plans of this or similar nature (including, but not limited to, Code
Section 409A), and to the administrative regulations and rulings promulgated thereunder. By accepting an Award under this Plan, a Participant agrees
to any amendment made pursuant to this Section 16.3 to any Award made under the Plan without further consideration or action.
16.4 CORRECTION OF ERRORS. Notwithstanding anything in any Award Agreement to the contrary, the Committee may amend an Award
Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of correcting errors occurring in connection with
the grant or documentation of an Award, including rescinding an Award erroneously granted, including, but not limited to, an Award erroneously
granted to an individual who does not qualify as an Eligible Participant on the date of grant. By accepting an Award under this Plan, a Participant
agrees to any amendment made pursuant to this Section 16.4 to any Award made under the Plan without further consideration or action.
ARTICLE 17 GENERAL PROVISIONS
17.1. 	RIGHTS OF PARTICIPANTS.
(a) 	No Participant or any Eligible Participant shall have any claim to receive any Award under the Plan. Neither the Company, its
Affiliates nor the Committee is obligated to treat Participants or Eligible Participants uniformly, and determinations made under the
Plan may be made by the Committee selectively among Eligible Participants who receive, or are eligible to receive, Awards (whether
or not such Eligible Participants are similarly situated).
(b) 	Nothing in the Plan, any Award Agreement or any other document or statement made with respect to the Plan, shall interfere with or
limit in any way the right of the Company or any Affiliate to terminate any Participant’s employment or status as an officer, or any
Participant’s service as a director, at any time, nor confer upon any Participant any right to continue as an employee, officer or director
of the Company or any Affiliate, whether for the duration of a Participant’s Award or otherwise.
(c) 	Neither an Award nor any benefits arising under this Plan shall constitute an employment contract with the Company or any Affiliate
and, accordingly, subject to Article 16, this Plan and the benefits hereunder may be terminated at any time in the sole and exclusive
discretion of the Committee without giving rise to any liability on the part of the Company or an of its Affiliates.

-- 66 of 74 --

(d) 	No Award gives a Participant any of the rights of a shareowner of the Company unless and until Shares are in fact issued to such person
in connection with such Award.
17.2. WITHHOLDING. The Company or any Affiliate shall have the authority and the right to deduct or withhold, or require a Participant to
remit to the Company or such Affiliate, an amount sufficient to satisfy the Company’s federal, state, and local taxes withholding obligations (including
any social tax obligation) required by law to be withheld with respect to any exercise, lapse of restriction or other taxable event arising as a result of the
Plan. The obligations of the Company under the Plan will be conditioned on such payment or arrangements and the Company or such Affiliate will, to
the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant. Unless otherwise
determined by the Committee at the time the Award is made or thereafter, any such withholding requirement may be satisfied, in whole or in part, by
withholding from the Award Shares having a Fair Market Value on the date of withholding equal to the amount that the Company determines is
necessary to satisfy its withholding obligation. All such elections shall be subject to any restrictions or limitations that the Committee, in its sole
discretion, deems appropriate.
17.3. SPECIAL PROVISIONS RELATED TO CODE SECTION 409A . It is intended that the payments and benefits provided under the Plan
and any Award shall either be exempt from the application of, or comply with the requirements of Code Section 409A. The Plan and all Award
Agreements shall be construed in a manner that effects such intent. Nevertheless, the tax treatment of the benefits provided under the Plan or any
Award is not warranted or guaranteed. Neither the Company, its Affiliates nor their respective directors, officers, employees or advisers (other than in
his or her capacity as a Participant) shall be held liable for any taxes, interest, penalties or other monetary amounts owed by any Participant or other
taxpayer as a result of the Plan or any Award.
17.4. UNFUNDED STATUS OF AWARDS . The Plan is intended to be an “unfunded” plan for incentive and deferred compensation. With
respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the
Participant any rights that are greater than those of a general creditor of the Company or any Affiliate. In its sole discretion, the Committee may
authorize the creation of grantor trusts or other arrangements to meet the obligations created under the Plan to deliver Shares or payments in lieu of
Shares with respect to Awards. This Plan is not intended to be subject to ERISA.
17.5. RELATIONSHIP TO OTHER BENEFITS. No payment under the Plan shall be taken into account in determining any benefits under any
pension, retirement, savings, profit sharing, group insurance, welfare or benefit plan of the Company or any Affiliate unless provided otherwise in such
other plan. Nothing contained in the Plan will prevent the Company from adopting other or additional compensation arrangements, subject to
shareowner approval if such approval is required; and such arrangements may be either generally applicable or applicable only in specific cases.
17.6. FRACTIONAL SHARES. No fractional Shares shall be issued and the Committee shall determine, in its discretion, whether cash shall be
given in lieu of fractional Shares or whether such fractional Shares shall be eliminated by rounding up or down.
17.7. 	GOVERNMENT AND OTHER REGULATIONS.
(a) 	Notwithstanding any other provision of the Plan, no Participant who acquires Shares pursuant to the Plan may, during any period of
time that such Participant is an affiliate of the Company (within the meaning of the rules and regulations of the Securities and Exchange
Commission under the 1933 Act), sell such Shares,

-- 67 of 74 --

unless such offer and sale is made (i) pursuant to an effective registration statement under the 1933 Act, which is current and includes
the Shares to be sold, or (ii) pursuant to an appropriate exemption from the registration requirement of the 1933 Act, such as that set
forth in Rule 144 promulgated under the 1933 Act.
(b) 	Notwithstanding any other provision of the Plan, if at any time the Committee shall determine that the registration, listing or
qualification of the Shares covered by an Award upon any Exchange or under any foreign, federal, state or local law or practice, or the
consent or approval of any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the
granting of such Award or the purchase or receipt of Shares thereunder, no Shares may be purchased, delivered or received pursuant to
such Award unless and until such registration, listing, qualification, consent or approval shall have been effected or obtained free of any
condition not acceptable to the Committee. Any Participant receiving or purchasing Shares pursuant to an Award shall make such
representations and agreements and furnish such information as the Committee may request to assure compliance with the foregoing or
any other applicable legal requirements. The Company shall not be required to issue or deliver any certificate or certificates for Shares
under the Plan prior to the Committee’s determination that all related requirements have been fulfilled. The Company shall in no event
be obligated to register any securities pursuant to the 1933 Act or applicable state or foreign law or to take any other action in order to
cause the issuance and delivery of such certificates to comply with any such law, regulation or requirement.
17.8. GOVERNING LAW. To the extent not governed by federal law, the Plan and all Award Agreements shall be construed in accordance
with and governed by the laws of the State of Delaware.
17.9. SEVERABILITY. In the event that any provision of this Plan is found to be invalid or otherwise unenforceable under any applicable law,
such invalidity or unenforceability will not be construed as rendering any other provisions contained herein as invalid or unenforceable, and all such
other provisions will be given full force and effect to the same extent as though the invalid or unenforceable provision was not contained herein.
17.10. 	NO LIMITATIONS ON RIGHTS OF COMPANY . The grant of any Award shall not in any way affect the right or power of the
Company to make adjustments, reclassification or changes in its capital or business structure or to merge, consolidate, dissolve, liquidate, sell or
transfer all or any part of its business or assets. The Plan shall not restrict the authority of the Company, for proper corporate purposes, to draft or
assume awards, other than under the Plan, to or with respect to any person. If the Committee so directs, the Company may issue or transfer Shares to an
Affiliate, for such lawful consideration as the Committee may specify, upon the condition or understanding that the Affiliate will transfer such Shares
to a Participant in accordance with the terms of an Award made to such Participant and specified by the Committee pursuant to the provisions of the
Plan.

-- 68 of 74 --

ADDENDUM ONE
For French Tax Residents and/or for French Employees affiliated to the French social security regime on a mandatory basis at Award Date
Options granted under The Coca-Cola Company 2014 Equity Plan to employees based in France (the "French Employees") of the Subsidiaries of The
Coca-Cola Company (the “Company”) may be granted under the terms of this Addendum One as follows:
1) Notwithstanding any other provision of the Plan, options granted to any French Employee who is a consultant, an "Administrateur," or a member of
the "Conseil de Surveillance," as these terms are defined in French Corporate law, and who does not have a work contract with the Company or its
Subsidiaries will be deemed to have not been granted an option pursuant to this Addendum One.
2) Notwithstanding any other provision of the Plan, the number of options offered through the Plan cannot exceed one third of the capital of the
Company.
3) Options may be granted only to French Employees who hold less than ten percent of the outstanding shares of the Company as of the Award
Date.
4) Notwithstanding any other provision of the Plan, any option with an exercise price on the date of grant of the option that is less than 80% of the
average of the market value of the underlying share during the 20 trading days preceding the date of grant shall be deemed to have not been granted
under this Addendum One.
5) Notwithstanding any other provision of the Plan, options cannot be granted during the 20 trading days after the payment of a dividend or after
an increase of capital reserved to the shareholders.
6) Notwithstanding any other provision of the Plan, no options can be granted during the ten trading days preceding or following the publication
of the annual financial consolidated account or the annual financial statement.
7) Notwithstanding any other provision of the Plan, no options can be granted during the period starting the date the corporate management of the
company is aware of information the publication of which could have a substantial consequence on the fair market value of the shares and ending
ten trading days after the publication of this information.
8) Notwithstanding any other provision of the Plan, the exercise price of an option shall be adjusted only upon the occurrence of the events strictly
specified under Article L. 225-181 of the French Commercial Code. Any reduction by the Company, to the exercise price of an outstanding and
unexercised option previously issued under this Addendum One, to the current fair market value of the underlying share shall be deemed to not
have been an option granted under this Addendum One.
9) Notwithstanding any other provision of the Plan, to the extent an option was exercisable by a French Employee at the time of his death, such option
shall remain exercisable for a maximum period of six months from the date of the French Employee’s death (including death during/after
Disability).

-- 69 of 74 --

ADDENDUM TWO
For French Tax Residents and/or for French Employees affiliated to the French social security regime on a mandatory basis at Award Date
The Committee has determined that it is necessary and advisable to establish a subplan for the purpose of permitting Performance Awards to qualify for
French specific tax and social security treatment. Therefore, Performance Awards granted under the Plan to employees and officers of Related
Companies in France (the “French Employees”) may be granted under the terms of this Addendum Two to the Plan and applying to the Award
Agreement, provided that such Awards shall not have terms that would not otherwise be allowed under the general terms of the Plan. The authorization
to grant Awards under this Addendum Two shall be for a limited period ending on the date of the Company’s 2024 annual shareowners’ meeting.
1) Unless otherwise defined herein, the terms defined in this Addendum Two shall have the same meanings as defined in the Plan and in the Award
Agreement. In the event of a conflict between the terms and conditions of the Plan, this Addendum Two and the Award Agreement, the terms and
conditions of the Plan shall prevail except for the following additional terms that shall be defined as follows:
“Disability” means disability as determined in categories 2 and 3 under Article L. 341-4 of the French Social Security Code.
“Related Companies” means the companies within the meaning of Article L. 225-197-2 of the French Commercial Code or any provision
substituted for same.
“Closed Period” means (i) ten quotation days preceding and the three quotation days following the disclosure to the public of the consolidated
financial statements or annual statement of The Coca-Cola Company; or (ii) the period as from the date the corporate management entities
(involved in the governance of the company, such as the Board, Committee, supervisory, in the case it would be disclosed to the public,
significantly impact the quotation of the shares of the Company, until ten quotation days after the day such information is disclosed to the public.
2) This Addendum Two shall be applicable to French Employees and corporate officers ( e.g., Président du Conseil d’Administration, Directeur
Général, Directeur Général Délégué, Membre du Directoire, Gérant de sociétés par actions ) of a Related Company and who is a French tax
resident and/or affiliated to the French social security regime on a mandatory basis at the Award Date.
3) Any Awards granted under this Addendum Two shall include, either:
a. An acquisition period of at least two years (at the end of which the shares are released to the French Employees) followed by a minimum two-
year holding period (during which the Shares cannot be disposed of). As from the end of the holding period, the shares shall be freely
transferable, subject to legal and regulatory provisions in force; or
b. An acquisition period of at least four years (at the end of which the shares are released to the French Employees). Shares released shall be
freely transferable, subject to legal and regulatory provisions in force.
4) Awards may be granted only to French Employees who hold less than ten percent of the outstanding Shares of the Company at the Award Date,
being specified that a grant cannot

-- 70 of 74 --

entitle a French Employee to hold more than ten percent of the outstanding Stock of the Company.
5) The Shares (i) shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of until the end of the two-year holding period
following the release date, and (ii) shall, if the French Employee’s continuous employment with the Related Companies shall terminate for any
reason (except as otherwise provided in items 9 and 10, herein) before the end of the performance period, be forfeited to the Company forthwith,
and all the rights of the French Employee to such Award Agreement shall immediately terminate.
6) Unless and until such time as Shares awarded are released to the French Employee, the French Employee shall have no ownership of the Shares
allocated to the awards and shall have no right to vote and to receive dividends, if applicable, subject to the terms, conditions and restrictions
described in the Plan, in the Award Agreement and herein.
7) For compliance purpose with French law, the Shares granted shall not be transferable during the Closed Period.
8) In the event of the death of a French Employee occurring prior to the release date, his/her heirs and assigns may claim the release of the Shares of
the deceased French Employee within six months following the date of death. Thereafter, the award will lapse and be null and void. Provisions of
the Award Agreement shall apply. However, the French Employee’s heirs shall not be bound by the holding period as defined in item 3 above, if
any.
9) In the event of the Disability of a French Employee occurring prior to the release date, the Shares will be issued and/or released to the French
Employee within the period defined in the Award Agreement and following the acknowledgement by the Company of the Disability. The French
Employee shall not be bound by the holding period as defined in item 3 above, if any.
10) Any additional and specific condition to the grant of Shares shall be contained in the Award Agreement (i.e., Continuous Service, performance
conditions, etc.).

-- 71 of 74 --

Exhibit 31.1
CERTIFICATIONS
I, James Quincey, Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	April 28, 2022
/s/ James Quincey
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of
The Coca-Cola Company

-- 72 of 74 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, Executive Vice President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	April 28, 2022
/s/ John Murphy
John Murphy
Executive Vice President and Chief Financial Officer of
The Coca-Cola Company

-- 73 of 74 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (“Company”) on Form 10-Q for the period ended April 1, 2022 (“Report”), I, James Quincey, Chairman of
the Board of Directors and Chief Executive Officer of the Company and I, John Murphy, Executive Vice President and Chief Financial Officer of the Company, each certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ JAMES QUINCEY
James Quincey
Chairman of the Board of Directors and Chief Executive Officer of The Coca-Cola Company
April 28, 2022
/s/ JOHN MURPHY
John Murphy
Executive Vice President and Chief Financial Officer of The Coca-Cola Company
April 28, 2022

-- 74 of 74 --